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Protein ubiquitination is a core regulatory principle in neuronal 
development. In this study, I used brain specific KO mice to investigate 
the roles of several HECT-type Nedd4 superfamily E3 ligases, i.e. 
Nedd4-1, Nedd4-2, WWP1, and WWP2, during brain development. I 
show that Nedd4-1 and Nedd4-2 are required for neuronal axonal 
growth and branching in the mouse central nervous system. Previously 
published data indicated that the lipid phosphatase PTEN may be a 
relevant substrate of Nedd4-1 and Nedd4-2. However, I show that 
aberrant PTEN ubiquitination is not involved in the impaired axon 
growth upon deletion of Nedd4-1 and Nedd4-2. Rather, PTEN limits 
Nedd4-1 expression at the translational level by modulating the activity 
of mTORC1, a protein complex that controls protein synthesis and cell 
growth. I further show that Nedd4-1 is one of the major targets of PTEN-
mTORC1 signaling in the control of neurite growth. In addition, I 
identify the deubiquitinase Usp9x as a binding partner of WWP1 and 
WWP2. WWP1 and WWP2 may counteract the function of Usp9x by 
interacting with Nuak1 and Nuak2, protein kinases that can be 
deubiquitinated and activated by Usp9x. Moreover, I show that Cdk5, a 
protein kinase with multiple roles in the nervous system, is 
ubiquitinated by WWP1 and WWP2 in vivo via a K63-linked 
polyubiquitin chain. Such ubiquitination of Cdk5 by WWP1 and WWP2 
may alter Cdk5 activation or subcellular localization and may thus 
affect multiple cellular processes during brain development. 
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Cdk5 Cyclin-dependent kinase 5 
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regulated 4 
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PTEN Phosphatase and tensin homolog 
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SVZ Subventricular zone 
VZ Ventricular zone 
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WWP WW domain-containing protein 
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1.1 Nerve Cells Development in the Murine Cerebral Cortex 
As the center of nervous system, the brain is the most complex 
mammalian organ with the cerebrum occupying the largest part. The murine 
cerebral cortex is comprised of billions of neurons, each of which 
communicates with others through thousands of synapses (Herculano-
Houzel et al., 2006). The resulting neuronal network contains trillions of 
synapses in a highly ordered manner and is responsible for cognitive 
functions (e.g. learning and memory), perceptions (e.g. hearing, vision, taste, 
olfaction, and somatic sensory), movements, and consciousness. The 
formation of this network is dependent on the development of neurons, which 
are specialized cells that allow the directional transfer of signals through their 
two types of protrusions: dendrites and axons. A neuron projects multiple 
dendrites to receive synaptic inputs, and a single extended axon to send 
synaptic outputs. In the mammalian cerebral cortex, the development of 
neurons is characterized by four distinctive but partially overlapping stages: 
first, neuronal progenitor cells proliferate and differentiate into neurons 
(neurogenesis); second, newly generated neurons move toward their final 
destination (migration); third, neurons project dendrites and axons 
(neuritogenesis); and fourth, synapses are formed between dendrites and 
axons  (synaptogenesis; Figure 1-1; reviewed by Parrish et al., 2007).  
1.1.1 Neurogenesis 
Three types of neurogenic progenitor cells reside in the developing 
neocortex: neuroepithelial cells, radial glial cells (RGCs), and intermediate 
progenitors. Neuroepithelial cells undergo symmetric cell division at the 
ventricular zone (VZ) to expand its population and subsequently generate 
neurons by asymmetric division. RGCs arise from neuroepithelial cells at the 
apical surface of the VZ. They also proliferate via symmetric cell division and 
generate neurons and intermediate progenitors by asymmetric cell division. 
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Intermediate progenitors divide only once to give rise to two postmitotic 
neurons in the subventricular zone (SVZ; Figure 1-1A; reviewed by Gotz and 
Huttner, 2005). 
1.1.2 Neuronal Migration 
The newly generated neurons in the neocortex migrate radially along 
the projections of RGCs from the VZ or the SVZ toward the cortical plate. 
Neurons generated in the early phase of neurogenesis migrate first and 
settle down at the marginal zone (MZ), whereas neurons generated in later 
phases overtake the existing neurons and migrate further (neurons i and ii in 
Figure 1-1B). Following this 'inside-out' fashion of neuronal migration, the 
deepest layer of the neocortex is established first (reviewed by Lambert de 
Rouvroit and Goffinet, 2001). 
Migration of neurons requires orchestrated activities of multiple cellular 
components, with the centrosome-derived cytoplasmic microtubules playing 
a central role. Steered by extracellular guidance cues, locomotion of the 
neuron is carried out by three successive but interdependent cellular modes: 
extension of the leading process, transition of the nucleus (nucleokinesis), 
and retraction of the trailing process. The centrosome of migrating neuron is 
positioned in front of the nucleus towards the direction of migration, a 
configuration called 'nucleus-centrosome coupling' that is crucial for 
nucleokinesis. After the leading process elongates along the projections of 
RGCs, the centrosome advances into the leading process and uncouples 
from the nucleus. The microtubule minus-end-directed motor proteins such 
as dynein and its associated proteins provide the pulling forces for 
nucleokinesis to restore the nucleus-centrosome coupling. Upon receiving 
the Reelin signal secreted by the Cajal-Retzius cells at the MZ, neurons 
detach from the RGC and stop migrating (reviewed by Frotscher, 1998; 
Honda et al., 2011). 
 




Neuritogenesis starts during migration (Figure 1-1C). Individual 
migrating neurons extend two main processes toward the MZ and the VZ, 
which later differentiate into dendrites and axons, respectively. At the initial 
stage of neuritogenesis, several signaling molecules such as cAMP, PI3K, 
and PAR6, showed polarized distribution in one of the neurites, contributing 
to the rearrangements of cytoskeleton in this specific neurite. Such signaling 
drives the extension of a single neurite, which will obtain the function of an 
axon later in development (reviewed by Arimura and Kaibuchi, 2007; Barnes 
and Polleux, 2009; Cheng and Poo, 2012).  
The developing axons need to be guided to the defined targets. This 
process is controlled by extracellular cues including chemoattractants and 
chemorepellants, such as Notch, semaphorins, ephrins, reelin and 
neurotrophins, in combination with the corresponding receptors expressed at 
the growth cones of extending axons. Activation of these receptors triggers 
intracellular signaling cascades, leading to rearrangements of cytoskeleton 
and asymmetric membrane trafficking that drive the axonal branching and 
growth cone turning. Therefore, the extending axons are allowed to navigate 
the environment to find the correct targets (reviewed by O’Donnell et al., 
2009; Tojima et al., 2011).  
Dendrites differ from axons in many morphological and functional 
aspects. Accordingly, morphogenesis of dendrites involves some different 
underlying mechanisms as that of axons. Intrinsic regulars such as 
transcriptional factors contribute to the neuronal type-specific dendritic 
patterns. Neurogenin-2, for example, is a basic helix-loop-helix (bHLH) 
transcription factor that has a crucial role in the specification of dendritic 
morphology of pyramidal neurons in the neocortex. Other transcription 
factors such as CREST and CREB respond to the Ca2+-dependent 
intracellular cascades and regulate the activity-dependent dendritic 
outgrowth. Importantly, extracellular cues that operate for axonal guidance, 
on the other hand, play roles in regulating the arborization of dendrites 
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(reviewed by Jan and Jan, 2010; Puram and Bonni, 2013). Therefore, 
dendrites establish their overall arborization patterns through a combination 
of intrinsic and extrinsic mechanisms. 
1.1.4 Synaptogenesis 
Synaptogenesis takes place mostly postnatally, which is in line with the 
fact that this process is strongly influenced by the activity within the 
developing neuronal network (Figure 1-1D). The initial contact between an 
axonal growth cone and a target neuron is mediated by various synaptic 
adhesion proteins, which interact with each other in a trans configuration in 
an isoform-specific manner to allow for the cell-type specificity of 
synaptogenesis. Upon the establishment of nascent synaptic contacts, 
synaptic organizing signals contributed by the adhesion proteins then 
coordinate the subsequent maturation process, during which hundreds of 
specific proteins are sorted to the pre- and postsynaptic compartments. In 
the mature synapse, presynaptic neurotransmitter releasing sites are 
opposed to the postsynaptic signal-receiving compartment, or the 
postsynaptic density. The pre- and post-synapse contains distinct sets of 
adhesion and scaffolding proteins that are required for equipping the 
synapse with the proper presynaptic neurotransmitter releasing machinery 
and postsynaptic receptors (reviewed by Brose, 1999; Garner et al., 2002; 
Siddiqui and Craig, 2011; Waites et al., 2005; Yamagata et al., 2003).  
1.1.5 Perspectives on Studies of Neuronal Development 
Dysregulation of any of these four steps of nerve cell development may 
lead to neurological or psychiatric disorders, such as Rett syndrome, Down's 
syndrome, Fragile X syndrome, or autism spectrum disorders (reviewed by 
Bagni and Greenough, 2005; Dierssen and Ramakers, 2006; Kaufmann and 
Moser, 2000; Pardo and Eberhart, 2007). Studies of the underlying molecular 
mechanisms of nerve cell development, therefore, is important for 
understanding the pathology of these disorders as well as normal brain 
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functions. In the past three decades, it has been established that the four key 
steps of nerve cell development are coordinated by defined signaling 
pathways mediated by protein and lipid phosphorylation, Ca2+ signaling, and 
protein ubiquitination (reviewed by Arimura and Kaibuchi, 2007; DiAntonio 
and Hicke, 2004; Kawabe and Brose, 2011; Takemoto-Kimura et al., 2010). 
However, if and how these pathways interact and contribute to the neuronal 
developing processes remains largely unexplored. 
Figure 1-1. Key Stages of Neuronal Development in the Rodent 
Neocortex 
In the ventricular zone, neuroepithelial cells undergo cell division to expand 
their population and generate radial glia cells (RGCs). (A) RGCs proliferate 
via symmetric cell division to generate neurons or intermediate progenitors 
(IP) by asymmetric cell division. (B) An IP divides only once at the 
subventricular zone to generate two neurons, which migrate vertically along 
the radial projections of RGCs toward the cortical plate. External cues 
secreted by Cajal-Retzius cells cause the detachment of neurons from the 
radial projection and stop the neuronal migration. Note that neurons migrate 
towards the cortical plate in an inside-out manner (neurons i and ii), so that 
the deepest layer of the cortex is established first. (C) During migration, 
neurons start extending neurites, which later differentiate into dendrites and 
axons. (D) Dendrites and axons further extend and branch to form initial 
contacts. Synaptic adhesion proteins then coordinate the recruitments of pre- 
and post-synaptic components for the formation of synapses. Adapted by 
permission from Macmillan Publishers Ltd: Nat. Rev. Neurosci. (Kawabe and 
Brose, 2011), Copyright, 2011. 
1.2 Ubiquitination 
Ubiquitination is a protein post-translational modification that involves 
the conjugation of one or more ubiquitin moieties to substrate proteins, and 
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thereby regulates the stability or function of the substrate proteins. This 
process is carried out by a sequential reaction catalyzed by three classes of 
enzymes: ubiquitin-activating enzymes (E1), ubiquitin-conjugating enzymes 
(E2), and ubiquitin ligases (E3). An E1 forms a high-energy thioester bond 
with an ubiquitin at the expense of ATP. The activated ubiquitin conjugated 
on the E1 is then transferred to an E2, which directly interacts with an E3. 
The E3 then mediates the conjugation of ubiquitin onto substrate proteins. E3 
ligases determine the substrate specificity by interacting with the substrate 
proteins, and they belong to either of the two families based on their domain 
structures: Really Interesting New Gene type ligases (RING finger-type E3 
ligases) and Homologous to E6-AP Carboxyl-Terminus type ligases (HECT-
type E3 ligases). RING finger-type E3 ligases transfer the ubiquitin moiety 
from E2 to substrates directly, whereas HECT-type E3 ligases first covalently 
bind to the ubiquitin moiety at a cysteine residue in their HECT domain and 
then transfer it to the substrates. In contrast to E1 and E2 enzymes, E3s 
have higher diversity in higher-order animals. Approximately 600 genes 
encode E3s in the human genome. Owing to their diversity, E3 ligases are 
considered to be the main determinant of the substrate specificity in the 
protein ubiquitination processes (Figure 1-2A; reviewed by Komander and 
Rape, 2012; Welchman et al., 2005). 
A single 76-amino acid long ubiquitin protein has seven lysine residues, 
all of which can be used for the formation of polyubiquitin chains. Lysine 48-
linked (K48-linked) polyubiquitin chains, in which the carboxyl-terminal 
glycine residue of one ubiquitin moiety is linked to the K48 of another 
ubiquitin moiety, direct protein degradation by the 26S proteasome. More 
recent studies have revealed that monoubiquitination and ubiquitin chains 
conjugated through the other six lysine residues also play important roles in 
the regulation of numerous cellular processes. K63-linked polyubiquitin 
chains, for example, have been reported to control DNA repair, NFκB 
activation, translational regulation, and endocytosis. Monoubiquitination or 
multi-monoubiquitination of proteins, on the other hand, has been shown to 
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regulate endocytosis and trafficking of plasma membrane proteins (Figure 1-
2B; reviewed by Ikeda and Dikic, 2008). 
Similar to phosphorylation or many of other protein posttranslational 
modifications, ubiquitination is a reversible process and can be reversed by 
the action of deubiquitinases (DUBs). Such dynamic regulation allows the 
protein ubiquitination procedure responding to various signals to regulate the 
fast-changing cellular processes. 
Figure 1-2. The Protein Ubiquitination Pathway 
(A) Protein ubiquitination is a sequential reaction catalyzed by three classes 
of enzymes. An ubiquitin-activating enzyme (E1) forms a thioester bond with 
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a free ubiquitin moiety at the expense of ATP. The activated ubiquitin is 
subsequently transferred to an ubiquitin-conjugating enzyme (E2), which is in 
turn recognized by an ubiquitin ligase (E3). HECT-type E3 ligases covalently 
bind the activated ubiquitin received from E2s on a cysteine residue in the 
HECT domain, and subsequently transfer the ubiquitin to a lysine residue on 
the substrate protein that is recognized by the substrate recognition domain 
(S) of the E3 ligase. On the other hand, RING finger-type E3 ligases directly 
transfer the activated ubiquitin from E2 enzymes to substrate proteins. (B) 
Functional consequences of protein Ubiquitination. Proteins conjugated with 
K48-linked polyubiquitin chains or K11-linked polyubiquitin chains are directly 
recognized by the 26S proteasome and targeted for degradation. Proteins 
conjugated with K63-linked polyubiquitin chains may have altered functions. 
Monoubiquitination or multi-monoubiquitination of proteins regulates the 
function or endocytosis of proteins. PPi, pyrophosphate; Ub, ubiquitin. 
Adapted by permission from Macmillan Publishers Ltd: Nat. Rev. Neurosci. 
(Kawabe and Brose, 2011), Copyright, 2011. 
1.2.1 Systematic Screening for Protein Substrates of E3 Ligase-
Specific Ubiquitination 
Despite the importance of protein ubiquitination in the regulation of 
multiple cellular processes, the comprehensive identification of specific 
substrates of individual E3 ligases has remained a challenge. Methods for 
globally quantitative assessment of protein amounts or protein stability, such 
as SILAC (Krüger et al., 2008), global protein stability profiling (Yen et al., 
2008), or iTRAQ labeling (Wiese et al., 2007) may give hints for substrate 
proteins that are modified through K48-linked polyubiquitination. However, 
recent studies have revealed the importance of monoubiquitination and 
ubiquitin chains conjugated through the other six lysine residues, which may 
not regulate the stability of substrate proteins. In addition, the alterations in 
protein amounts or stability detected using those methods may be a 
secondary effect rather than a direct consequence of protein ubiquitination. 
Therefore, direct assessment of ubiquitin-modified proteomes, or 
ubiquitomes, is more informative for the identification of ubiquitination 
substrates. 
Systematic identification of ubiquitination substrates can be achieved by 
the application of protein microarrays. Using purified recombinant E3 ligases 
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on protein microarrays, one can perform binding assays to screen for binding 
proteins, or perform in vitro ubiquitination assays using fluorescently-labeled 
ubiquitin to screen for potential protein substrates. Experiments using protein 
microarrays and the recombinant E3 ligase Rsp5, a yeast orthologue of 
vertebrate Nedd4, identified several previously known as well as putative 
novel binding partners and ubiquitination substrates of Rsp5, indicating the 
validity of this method (Gupta et al., 2007; Kus et al., 2005). 
Purification of the ubiquitomes from cells, followed by identification of 
purified proteins using mass spectrometric analyses can also be applied to 
identify ubiquitination substrates. However, protein deubiquitination mediated 
by DUBs is a confounding factor, whose circumvention requires substantial 
enrichment of ubiquitination and low complicity samples. One of the 
approaches to circumvent the problems posed by DUBs is to overexpress 
the His6-tagged-ubiquitin in cells, followed by purification of the His6-ubiquitin-
modified ubiquitomes using Ni-NTA chromatography under denaturing 
conditions (Peng et al., 2003). The reliability of this method, however, is 
questionable as overexpression of the His6-ubiquitin can result in artificial off-
target ubiquitination. 
The development of tandem-repeated ubiquitin-binding entities (TUBEs) 
offers a solution to purify endogenous ubiquitinated proteins while at the 
same time protecting them from being deubiquitinated by DUBs. As 
compared to single ubiquitin associated domain (UBAs), TUBEs show higher 
affinity to K48- or K63-lined tetra-ubiquitin, and thus can be useful to 
efficiently purify endogenous K48-linked or K63-linked polyubiquitinated 
proteins from cells (Hjerpe et al., 2009). The purification and identification of 
monoubiquitinated proteins using TUBEs, nevertheless, is not an ideal 
approach given the rather weak affinities between TUBEs and 
monoubiquitinated proteins. 
Further advances in purification of endogenous ubiquitomes involved 
the enrichment of ubiquitomes at the peptide level instead of at the protein 
level. Following trypsin digestion of proteins, the resulting peptides containing 
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di-glycine ubiquitin remnants left on the lysine residues (K-ε-GG) can be 
immunopurified using a monoclonal antibody specific to K-ε-GG. This 
approach reduces sample complexity for mass spectrometric analysis, 
resulting in an increased signal-to-noise ratio and the identification of a 
greater number of ubiquitinated sites. In addition, peptides containing K-ε-GG 
are contributed by endogenous E3 ligases, leading to more reliable 
identification of physiological substrates (Kim et al., 2011; Figure 1-3).  
In summary, various strategies have been developed to systematically 
identify the ubiquitination substrates of a given E3 ligase, and each of them 
has advantages and disadvantages. Combining more than one strategy may 
increase the validity of identification results. In addition, methods such as in 
vitro ubiquitination assays or in vivo ubiquitination assays can be applied to 
validate the screening results.  
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Figure 1-3. Quantitative Assessment of the Ubiquitin-Modified 
Proteome at the Peptide Level 
Cell lysates containing ubiquitinated proteins were trypsinized, and the 
resulting peptides containing di-glycine ubiquitin remnants (GG) left on the 
lysine residues were immunopurified with an anti-GG antibody. The GG-
modified peptides were then subjected to the liquid chromatography-tandem 
mass spectrometric (LC-MS/MS) analyses for identification and 
quantification. The identified GG-modified peptides were assigned to the 
corresponding proteins. Adapted from (Kim et al., 2011) with permission from 
Elsevier, Copyright, 2011. 
1.3 Roles of the HECT-Type Nedd4 Superfamily E3 Ligases 
in Neuronal Development 
The murine Neuronal precursor cell-expressed Developmentally Down-
regulated 4 (Nedd4) superfamily belongs to the HECT type E3 ligases family 
and contains eight members that share similar domain structures, which are 
consisted of an N-terminal C2 domain, two to four tryptophan-rich WW 
domains at the central region, and a C-terminal HECT domain (reviewed by 
Rotin and Kumar, 2009). The C2 domain acts as a Ca2+ sensor that mediates 
the Ca2+-dependent membrane targeting of the ligase as well as protein-
protein interactions, including the intramolecular interaction with the HECT 
domain that leads to autoinhibition of the ligase activity (Wang et al., 2010). 
WW domains recognize and bind to the proline-rich motif of the substrates 
(e.g. PPxY or LPxY, where ‘x’ stand for any amino acids), and thus are 
critical for substrate proteins recognition. The HECT domain is essential for 
ubiquitination of substrates by forming a thioester intermediate with an 
ubiquitin moiety at a conserved cysteine residue in the C-terminal region, and 
then transfers the ubiquitin to substrates (Figure 1-4; reviewed by Rotin and 
Kumar, 2009). 
	   Introduction	  
12	  
	  
Figure 1-4. Nedd4 Superfamily E3 Ubiquitin Ligases in Mus musculus 
There are eight members in the Nedd4 superfamily of the mouse genome. All 
of them share similar domain structures, including an N-terminal C2 domain, 
several WW domains at the central region, and a C-terminal HECT domain. 
The C2 domain acts as a Ca2+ sensor to mediate the Ca2+-dependent lipid 
binding as well as protein-protein interactions. WW domains mediate the 
interactions with substrate proteins and determine the substrate specificity. 
The HECT domain is essential for conjugation of ubiquitin onto substrate 
proteins by forming a thioester bond with an ubiquitin at a conserved cysteine 
residue, and then transferred the ubiquitin to the substrates. 
1.3.1 Nedd4-1 and Nedd4-2 
Nedd4-1 was initially identified in a screen for developmentally 
downregulated genes in embryonic mouse brains. Since its discovery, other 
members of the Nedd4 superfamily were subsequently identified and cloned, 
including Nedd4-2, the closest isoform of Nedd4-1. Studies on Nedd4-1 and 
Nedd4-2 deficient mice indicated that Nedd4-1 and Nedd4-2 are essential for 
several basic cellular functions. Conventional Nedd4-1 KO mice exhibit 
delayed embryonic development, reduced growth and body weight, and 
neonatal lethality, likely because of reduced insulin-like growth factor 1 (IGF-
1)- and insulin- dependent signaling (Cao et al., 2008). Conventional Nedd4-
2 KO mice, on the other hand, exhibit increased expression of epithelial 
sodium channel (ENaC) in lungs, leading to increased airway Na+ 
reabsorption, depleted airway surface liquid volume, collapsed lungs, and 
perinatal lethality because of the inability to breath (Boase et al., 2011). 
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Regarding their roles in the development of neurons, recent studies 
based on KO or KD strategies revealed that Nedd4-1 and Nedd4-2 are 
important for neurite outgrowth (Figure 1-5). Mouse neurons lacking Nedd4-1 
show reduced length and complexity of dendrites. The small GTPase Rap2A 
was identified as the relevant substrate, which is monoubiquitinated or di-
ubiquitinated via a K63-linked chain by Nedd4-1. Ubiquitination of Rap2A by 
Nedd4-1 blocks the interaction of Rap2A with TNIK, a serine/threonine 
kinase whose activation by Rap2A leads to reduced dendritic growth. 
Therefore, the Nedd4-1-mediated Rap2A ubiquitination results in stronger 
growth and arborization of dendrites in mouse neurons (Kawabe et al., 
2010). 
In a complementary study, knock down (KD) of Xenopus laevis Nedd4 
(xNedd4) was reported to reduce the axonal branching of Xenopus laevis 
retinal ganglion neurons (Drinjakovic et al., 2010). PTEN was identified as 
the relevant substrate being polyubiquitinated and targeted to proteosomal 
degradation by xNedd4. This notion is supported by a previous report 
showing that KO of PTEN causes hypertrophy of neurites (Kwon et al., 
2006). In addition, experiments employing concomitant KD of both PTEN and 
xNedd4 rescued the reduced axonal branching phenotype they observed 
upon xNedd4 KD  (Drinjakovic et al., 2010). However, whether PTEN is the 
physiological substrate of Nedd4-1 remains highly controversial, as an 
independent report indicated that PTEN is not affected in the Nedd4-1 KO 
mouse embryonic fibroblasts (Fouladkou et al., 2008). Several other groups 
also identified alternative E3 ligases for PTEN, including XIAP, WWP2, and 
CHIP (Ahmed et al., 2012; Maddika et al., 2011; Van Themsche et al., 2009). 
Notably, xNedd4 is more homologous to mouse Nedd4-2, suggesting the 
possibility that PTEN is regulated by mouse Nedd4-2, and thus no evidence 
of PTEN misregulation was obtained in Nedd4-1 KO mouse embryotic 
fibroblasts (Fouladkou et al., 2008). 
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Figure 1-5. Nedd4 Promotes the Growth and Branching of Neurites 
(A) Hippocampal CA1 neurons from a NEX-Cre;Nedd4-1f/f mouse (left two 
panels) show less complex dendritic structures as compared to control 
neurons from a Nedd4-1f/f mouse (right two panels). Scale bars, 20 µm. 
Adapted from (Kawabe et al., 2010) with permission from Elsevier, Copyright, 
2010. (B) Axon terminals of a Xenopus laevis retinal ganglion neuron shows 
fewer branches upon KD of xNedd4 (right two panels) as compared to the 
control (left two panels). Scale bar, 20 µm. Adapted from (Drinjakovic et al., 
2010) with permission from Elsevier, Copyright, 2010. 
1.3.2 WWP1 and WWP2 
WWP1 and WWP2 were originally identified as members of the Nedd4 
superfamily based on the presence of tandem WW domains and a domain 
structure similar to that of Nedd4-1 (Pirozzi et al., 1997). Conventional 
WWP1 KO mice show increased bone formation as they age, which is 
accompanied by elevated levels of molecules important for osteoblast 
differentiation such as JunB, Runx2, and CXCR4 (Shu et al., 2013). WWP1 
is often upregulated at both mRNA and protein levels in human breast and 
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prostate cancers, indicating an oncogenic role of WWP1. Accordingly, RNAi 
knockdown of WWP1 suppresses the proliferation of breast and prostate 
cancer cell lines (Chen et al., 2006, 2009; Li et al., 2009; Nguyen Huu et al., 
2008). On the other hand, WWP2 KO mice develop malformations of the 
craniofacial region, which is associated with monoubiquitination of the 
transcription factor Goosecoid by WWP2 (Zou et al., 2011). In addition, 
WWP2 is also implicated in the polyubiquitination and subsequent 
degradation of PTEN, and therefore plays a role in PI3K-dependent signaling 
(Maddika et al., 2011). Although multiple studies have indicated roles of 
WWP1 and WWP2 in general cellular functions, their roles in neuronal 
development remain mostly unexplored.  
Interestingly, in a large-scale RNAi KD screening, the C. elegans 
orthologue of mammalian WWP1 and WWP2 (CeWWP-1) was identified as a 
candidate gene involved in synaptogenesis at neuromuscular junctions 
(Sieburth et al., 2005). In a subsequent study, the morphological changes in 
presynaptic terminals were characterized in loss-of-function mutants of 
genes that are related to synaptic transmission. CeWWP-1 was found to 
have significant functional correlations with two presynaptic active zone 
proteins: sad-1, an orthologue of mammalian sad-A and sad-B; and syd-2, an 
orthologue of mammalian α-liprin (Ch’ng et al., 2008). Of note, studies on 
mouse SAD-A and SAD-B kinases revealed their important roles in the 
regulation of neuronal polarity formation (Kishi et al., 2005). Together, these 
studies indicate that mammalian WWP1 and WWP2 may play roles in 
polarity formation and/or synaptogenesis of neurons. 
1.4 Roles of PTEN in Neuronal Development 
Phosphatase and tensin homolog (PTEN) is one of the most frequently 
mutated genes found in multiple tumor types. PTEN is a tumor suppressor 
and a lipid phosphatase that converts phosphatidylinositol-3,4,5-
trisphosphate (PtdInsP3) into phosphatidylinositol-4,5-bisphosphate 
(PtdInsP2) and thereby antagonizes the phosphoinositide-3-kinase-
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dependent (PI3K-dependent) signaling cascades, such as those involved in 
cell proliferation, cell survival, and protein synthesis (reviewed by Song et al., 
2012; Figure 1-6). The prominent functions of PTEN, therefore, make PTEN 
a prime modulator of numerous cellular processes, including the 
development of neurons. 
In developing mouse brains, the role of PTEN in neurogenesis in vivo 
was first revealed by a study using Nestin-Cre;PTENf/f mouse line, a neural 
progenitor specific conditional PTEN KO mouse line. The Nestin-Cre;PTENf/f 
mice exhibit enlarged brains because of increased cell proliferation and 
decreased cell death (Groszer et al., 2001). A subsequent study further 
indicated that PTEN null neural progenitor cells show longer maintenance of 
the stem cell-like properties, increased G0-G1 cell cycle entry, and 
decreased growth factor dependency. These data indicate that PTEN 
operates to suppress the self-renewal capacity of neural progenitor cells 
(Groszer et al., 2006). 
On the other hand, conditional KO of PTEN in postmitotic neurons in 
mouse brains leads to hypertrophy of neurites and neuronal somata (Chow 
et al., 2009; Kwon et al., 2001, 2006). Deletion of PTEN in neurons also 
results in increased density of spines, many of which show abnormal 
morphology such as lack of the distinct mushroom-shaped termini, enlarged 
presynaptic terminals packed with increased numbers of synaptic vesicles 
but no obvious corresponding postsynaptic density, and subsequent aberrant 
synaptic transmission (Fraser et al., 2008; Luikart et al., 2011). Moreover, KD 
of PTEN in cultured neurons results in multiple axons projecting from a single 
neuron, which is caused by abnormal inhibition of the GSK3β activity (Jiang 
et al., 2005). In short, these reports indicate that PTEN plays critical roles in 
multiple stages of neuronal development, including regulation of neuronal 
proliferation, neurite outgrowth, synapse development, and neuronal polarity 
formation. 
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Figure 1-6. Major Cellular Functions of the PI3K/PTEN-Dependent 
Signaling Pathways 
The PI3K/PTEN-dependent signaling plays key roles in regulating multiple 
cellular functions. PI3K catalyzes the phosphorylation of PtdInsP2 to 
generate PtdInsP3 in response to stimulations (e.g. growth factors). PTEN 
antagonizes the effect of PI3K by converting PtdInsP3 back to PtdInP2. 
Elevated PtdInsP3 levels lead to the phosphorylation of AKT, which further 
regulates signaling cascades such as those involved in cell survival, protein 
synthesis, and cell cycle progression. 
1.5 Roles of Cdk5 in Neuronal Development 
Cyclin-dependent kinase 5 (Cdk5) was initially identified based on its 
close sequence homology to the human cdc2 kinase and was therefore 
considered as a member of the serine/threonine cyclin-dependent kinase 
(Cdk) family (Lew et al., 1992; Meyerson et al., 1992). Unlike other members 
in the Cdk family, Cdk5 does not directly act in cell cycle regulation. In 
addition, the activation of Cdk5 does not depend on the binding to cyclin, but 
rather on binding to its specific activators, p35 and p39. Although Cdk5 is 
ubiquitously expressed in all tissues, its highest expression and 
corresponding kinase activity are detected in postmitotic neurons because of 
the neuron-specific expression patterns of p35 and p39 (Tang et al., 1995; 
Tsai et al., 1993, 1994). Since the cloning of Cdk5, numerous studies have 
discovered critical roles of Cdk5 in the nervous system, including the 
development of neurons (Figure 1-7; reviewed by Dhavan and Tsai, 2001; Su 
and Tsai, 2011). 
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Cdk5 KO mice die perinatally and show severe neocortical lamination 
deficits, as the newborn neurons in Cdk5 KO brains are unable to migrate 
through the earlier-generated neurons (Ohshima et al., 1996, 2007). 
Interestingly, these defects found in Cdk5 KO mice are recapitulated in p35 
KO and p35;p39 double KO mice. Notably, p35 KO mice are viable and show 
a milder phenotype as compared to Cdk5 KO and p35;p39 double KO mice. 
(Chae et al., 1997; Ko et al., 2001). These studies on the respective KO 
animals indicate that activation of Cdk5 by p35 or p39 is essential for proper 
neuronal migration and neocortical lamination during embryonic cortical 
development. Several key substrates have been reported as phosphorylation 
targets of Cdk5 in neuronal migration, such as NUDEL, a Lis1-interating 
protein whose intracellular distribution and interaction with dynein are 
affected by Cdk5-mediated phosphorylation (Niethammer et al., 2000; Sasaki 
et al., 2000); the tyrosine kinase FAK, which is phosphorylated by Cdk5 to 
promote the microtubule organization for nucleokinesis during neuronal 
migration (Xie et al., 2003); and doublecortin (Dcx), whose phosphorylation 
by Cdk5 decreases the affinity to microtubules and thus increases 
microtubule dynamics to allow for neuronal migration (Tanaka et al., 2004). 
In addition to the roles of Cdk5 in neuronal migration, Cdk5 also plays 
key roles in the regulation of neurite outgrowth and axonal pathfinding during 
neuronal development. Overexpression of a dominant negative Cdk5 variant 
(Cdk5 D144N) in cultured neurons causes a reduction in neurite outgrowth, 
whereas Cdk5/p35 overexpression leads to longer neurites (Nikolic et al., 
1996; Paglini et al., 1998). One of the identified substrates in this regard is 
p21-activated kinase 1 (Pak1), whose kinase activity is inhibited upon 
phosphorylation by Cdk5, and its inhibition promotes actin dynamics to allow 
for neurite outgrowth (Nikolic et al., 1996). Further studies have also 
indicated the importance of Cdk5-mediated phosphorylation of receptor 
tyrosine kinase, TrkB, for BDNF-stimulated neurite outgrowth (Cheung et al., 
2007), and phosphorylation of collapsing response mediator protein-2 
(CRMP-2) for semaphorin 3A-induced growth cone collapse (Brown et al., 
2004). 
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Cdk5 is localized to neuronal synapses (Humbert et al., 2000). Acute 
Cdk5 gain-of-function in vivo also results in a dramatic increase in synapse 
numbers (Fischer et al., 2005). Correspondingly, the membrane associated 
guanylate kinase family member CASK was identified as a presynaptic 
substrate of Cdk5. Phosphorylation of CASK by Cdk5 recruits CASK to 
presynaptic terminals, where it interacts with several presynaptic proteins, 
including Neurexin, Veli, and Mint1, and thereby promotes synapse formation 
(Samuels et al., 2007). On the other hand, the postsynaptic role of Cdk5 
during neuronal development was revealed by a study showing that the 
Cdk5-dependent phosphorylation of the N-terminal domain of PSD-95 is 
important for regulating the clustering of PSD-95, as well as some of the 
postsynaptic receptors such as NMDA receptors (Morabito et al., 2004). 
Together, these results indicate a role of Cdk5 in the formation and/or 
maintenance of synapses. 
Figure 1-7. Roles of Cdk5 in the Development of Mammalian Neurons 
Cdk5 activity is crucial for multiple cellular processes during mammalian 
neuronal development. The activation of Cdk5 requires the binding to the 
Cdk5 activator, p35. Upon activation, Cdk5 regulates various neuronal 
developmental processes such as neuronal migration, neurite outgrowth, 
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axon pathfinding, and synapse formation. Multiple substrate proteins that are 
phosphorylated by Cdk5 have been identified to be relevant for the regulation 
of these processes. Dcx, doublecortin; NUDEL,  nudE nuclear distribution 
gene E homolog-like 1; FAK, focal adhesion kinase;  Pak1, p21-activated 
kinase 1; TrkB, neurotrophic tyrosine kinase receptor type 2; CRMP-2, 
collapsing response mediator protein-2; PSD-95, postsynaptic density 
protein-95. 
1.6 Aims of the Present Study 
The present study was designed to unveil the roles of several ubiquitin 
E3 ligases of the Nedd4 superfamily (Nedd4-1, Nedd4-2, WWP1, and 
WWP2) in rodent brain development, and to characterize possible interplays 
between ubiquitination and other signaling pathways such as protein 
phosphorylation during neuronal development.  
In an attempt to resolve the long-lasting dispute on whether PTEN is a 
physiological substrate of Nedd4-1 and Nedd4-2, I focused in the first part of 
this study on clarifying the relationship between PTEN and the Nedd4 
subfamily E3 ligases, Nedd4-1 and Nedd4-2, in neurite development. In the 
second part of this study, I focused on characterizing the roles of the WWP 
subfamily E3 ligases, WWP1 and WWP2, in the developing mouse brain by 
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2 Materials and Methods 
2.1 Animals 
The Nedd4-1f/f (Kawabe et al., 2010), Nedd4-2f/f (Kimura et al., 2011), 
WWP1f/f, and WWP2f/f mouse lines were generated by Dr. Hiroshi Kawabe 
and Prof. Dr. Nils Brose. The NEX-Cre mouse line was generated and 
provided by Dr. Goebbles and Prof. Dr. Klaus A. Nave (Goebbels et al., 
2006). The PTENf/f mouse line was generated and provided by Dr. Hong Wu 
(Groszer et al., 2001). All animal experiments were approved by the 
responsible local government (Landesamtes für Verbraucherschutz und 
Lebensmittelsicherheit Niedersachsen) and conducted in compliance with 




Acrylamide/N,N'-Methylene-bis-Acrylamide National Diagnositic 
Adenosine Triphosphate (ATP) Sigma-Aldrich 
Agarose (UltraPure agarose) Invitrogen 
Ammonium Persulfate (APS) Sigma-Aldrich 
Ampicillin Invitrogen 
Aprotinin Roche 
Bacto-Agar DIFCO, BD 
Bacto-Casamino Acids DIFCO, BD 
Bacto-Peptone DIFCO, BD 
Bacto-Yeast Extract DIFCO, BD 
Boric Acid Sigma-Aldrich 
Bovine serum albumin (BSA), Fraction V  Pierce, Thermo 
CHAPS Biomol Feinchemikalien 
Comassie Brilliant Blue R250 BioMol Feinchemikalien 
Cycloheximide Sigma-Aldrich 
Darbecco Modified Eagle's Medium (D'MEM) Gibco, Invitrogen 
Dimethyl Sulfoxide (DMSO) Sigma-Aldrich 
Dithiothreitol (DTT) Sigma-Aldrich 
DNA Ladder Mix Sample, GeneRuler Fermentas 
dNTPs GE Healthcare 
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Skim Milk Nestle 
ECL Reagent Amersham, GE Healthcare 
Ethanol Sigma-Aldrich 
Ethidium Bromide (1% solution) Carl Roth 
Ethylene Glycol Tetraacetic Acid (EGTA) Sigma-Aldrich 




Glutathione (GSH) Sigma-Aldrich 
Glycerol Sigma-Aldrich 
Glycine Sigma-Aldrich 
Goat Serum Gibco, Invitrogen 
HEPES  Sigma-Aldrich 
Hydrochloric Acid (HCl) Sigma-Aldrich 
Iodoacetamide Sigma-Aldrich 
IPTG BioMol Feinchemikalien 
Kanamycin Invitrogen 
Leupeptin Roche 
Luria Broth (LB) Sigma-Aldrich 
Magnesium Chloride (MgCl2 6H2O) Sigma-Aldrich 
Methanol Sigma-Aldrich 
N-Ethylmaleimide (C6H7NO2, NEM) Sigma-Aldrich 
Neurobasal A Medium Gibco, Invitrogen 
N'N'N'-Tetramethylethyl Enediamine 
(TEMED) BioRad 
Opti-MEM I Invitrogen 
Phosphate Buffered Saline (PBS) PAA Laboratories 
Phenylmethylsulfonyl Fluoride (PMSF) Roche 
Protein Molecular Weight Standards Invitrogen 
Rapamycin Cell Signaling 
Restriction Endonucleases New England Biolabs (NEB) 
RNase OUT Invitrogen 
Sodium Butyrate Merck 
Sodium Chloride Sigma-Aldrich 
Sodium Deoxycholate Sigma-Aldrich 
Sodium Dodecyl Sulfate (SDS) Roche 
Sodium phosphate (NaH2PO4) Roche 
Sucrose Sigma-Aldrich 
Triton X-100 Roche 
Tween 20 Sigma-Aldrich 
Ubiquitin Boston Biochem 
X-Gal BioMol 
Z-Leu-Leu-Leu-CHO (MG-132) Boston Biochem 
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2.2.2 Enzymes from Commercial Sources 
Gateway LR Clonase Enzyme Mix Invitrogen 
Alkaline Phosphatase Roche 
DNaseI (RNase free) Roche 
Pfu Polymerase Stratagene 
SuperScript III RNase H reverse transcriptase Invitrogen 
SYBR Green PCR master mix Applied Biosystems 
T4 DNA Ligase Invitrogen 
Taq Polymerase (REDTaq) Sigma-Aldrich, D4309 
Ubiquitin Activating Enzyme (UBE1) Boston Biochem 
UbcH5b Boston Biochem 
UbcH6 Boston Biochem 
UbcH7 Boston Biochem 
2.2.3 Kits 
PureLink Quick Plasmid Miniprep Kit Invitrogen 
PureLink HiPure Plasmid Midiprep Kit Invitrogen 
PureLink HiPure Plasmid Maxiprep Kit Invitrogen 
EndoFree Plasmid Maxi Kit QIAGEN 
PureLink Gel Extraction Kit Invitrogen 
QuickChange II Site-Directed Mutagenesis Kit  Stratagene 
TOPO TA Cloning Kit Invitrogen 
PTEN Phosphatase Activity Kit Echelon 
NucleoSpin RNA XS Kit Macherey-Nagel 
BCA Protein Assay Kit Thermo, Pierce 
2.2.4 Bacterial Strains 
E. coli XL-1 Blue competent cells Stratagene 
E. coli Electro10-Blue competent cells Stratagene 
E. coli JM109 competent cells Promega 
E. coli TOP10 competent cells Invitrogen 
E.coli ccdB survival competent cells Invitrogen 
E. coli BL21 Rosetta competent cells Stratagene 
2.2.5 Vector Plasmids 
pCRII TOPO Invitrogen 
pCRII TOPO-WWP2 WT Provided by Dr. Mika-Kishimoto Suga 
pCRII TOPO-Myc-Cdk5 WT Generated in this study 
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pCIG-Flag-Nuak1 Provided by Dr. Franck Polleux 
pCIG-HA-Nuak2 Provided by Dr. Franck Polleux 
pCX-myrVenus Provided by Dr. Anna-Katerina Hadjantonakis 
pCIneoHA Provided by Dr. Hiroshi Kawabe 
pCMVdeltaR8.2 Provided by Prof. Dr. Pavel Osten 
pCIneoHA-p25 Generated in this study 
pClneoMyc Provided by Dr. Hiroshi Kawabe 
pCIneoMyc-Cdk5 WT Generated in this study 
pCIneoMyc-WWP1 WT Provided by Dr. Mika-Kishimoto Suga 
pcDNA3.1/nV5-DEST Invitrogen 
pcDNA3.1/nMyc-DEST Generated in this study 
pcDNA3.1/nMyc-Tubulin4A Generated in this study 
pcDNA3.1/nMyc-Uba1 Generated in this study 
pcDNA3.1/nMyc-Prkar1b Generated in this study 
pcDNA3.1/nMyc-Map3k6 Generated in this study 
pDONR221-Uba1 DNASU #HsCD00076423	  
pDONR221-Prkar1b DNASU #HsCD00296901 
pEF1-V5-Usp9x Provided by Dr. Hiroshi Kawabe 
pENTR223-Map3k6 DNASU #HsCD00505767 
pENTR223-TUBA4A DNASU #HsCD00511991 
pFUGW Salk Inst., Dr.Inder M. Verma 
pFUGW-iCre Provided by Dr. Richard L. Huganir 
pFUGW-WWP1 WT Generated in this study 
pFUGW-WWP2 WT Generated in this study 
pGEX4T-1 GE Healthcare Life Sciences 
pGEX4T-1 WWP1 WT Provided by Dr. Hiroshi Kawabe 
pGEX4T-1 WWP1 C886S Generated in this study 
pGEX6P-1 GE Healthcare Life Sciences 
pGEX6P-1-Cdk5 WT Generated in this study 
pGEX6P-1-Cdk5 P234A, 
Y236F Generated in this study 
pGEX6P-1-WWP2 WT Provided by Dr. Hiroshi Kawabe 
pGEX6P-2-p35 Addgene #24895 
pRRLsinPPT-CMV-WPRE Provided by Dr. Luigi Naldini 
pRRLsinPPT-CMV-WPRE-
Myc-Cdk5 WT Generated in this study 
pMalC2 New England Biolabs 
pMalC2-p25 Generated in this study 
pMD2.G Provided by Prof. Dr. Pavel Osten 
pRaichuMyc Provided by Dr. Hiroshi Kawabe 
pRaichuMyc-Cdk5 WT Provided by Dr. Hiroshi Kawabe 
pRaichuMyc-Cdk5 K61R Generated in this study 
pRK5-HA-Ubiquitin Provided by Dr. Hans-Jürgen Kreienkamp 




Oligonucleotide primers used in the present study are listed below. 
They were synthesized in the Max-Planck-Institute for Experimental Medicine 
DNA Core Facility on an ABI 5000 DNA/RNA synthesizer. Restriction sites 
used for molecular cloning are underlined when applicable. 
Primer # Sequence (5'-3') Rest. site 
28606 AACGAATTCGCCCAGCCCCCACCGG  EcoRI 
28607 TTCCGCTCGAGTCACCGATCCAGGCCTAGG XhoI 
30937 GCGCCAAGCTTACCATGGAACAGAAACTGATCTCTGAAGAAGACCTGGAT HindIII 
30938 ATCCAGGTCTTCTTCAGAGATCAGTTTCTGTTCCATGGTAAGCTTGGCGC HindIII 
31918 ACCAAGCTGGCAGACTTTAAGCCCTACCCAATGTACCC  
31919 GTAGGGCTTAAAGTCTGCCAGCTTGGTCATGGCAGGCC  
27283 GTTCTCGAGCTATGGGGGACAGAAGTCAG XhoI 
26356 AGCATGAACCACCAGGTCA (RT-qPCR Nedd4-1 forward)  
26357 TTTTTCCGAATCCATCATCC (RT-qPCR Nedd4-1 reverse)  
26358 AATGACCTGGGCCCTCTT (RT-qPCR Nedd4-2 forward)  
26359 GTAAAACGTGCGGCCATC (RT-qPCR Nedd4-2 reverse)  
26360 CATTGAGATTGCCGCTTACA (RT-qPCR Neurofilament H forward)  
26361 ACTCGGACCAAAGCCAATC (RT-qPCR Neurofilament H reverse)  
19900 ATCCCTCCACCCTATGACAA  
19901 GCCCCAGGTAAGCAAACTT  
11282 GGATCTGCTGGCCCCATAC  
11283 CTTTCCAACGCCAGCACCT  
- GGCTCATGACCACAGTCCA  (RT-qPCR GAPDH forward)  
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- TCCACAGTCTTCTGGGTGG  (RT-qPCR GAPDH reverve)  
30007 ACAGGATCCACCATGGAGCAGAAGCTTATCAGCG BamHI 
2.2.7 Antibodies 
Primary antibodies used in the present study 
Antibody Host Species Origin 
Usage and Dilution 
WB IHC ICC 
Actin (AC40)  Mouse Sigma-Aldrich 1:500 - - 
Actin Rabbit Sigma-Aldrich 1:2000 - - 




Signaling 1:2000 - - 
Ankyrin G Rabbit Santa Cruz - 1:400 1:400 
Cdk5 Rabbit Santa Cruz 1:200 - - 
Cdk5 (DC19) Mouse Millipore 1:200 - - 
Cre Mouse Sigma 1:200 1:200 - 
Cux1 Rabbit Santa Cruz - - 1:200 
FLAG (M2) Mouse Sigma 1:1000 - 1:1000 
GFP (7.1/13.1) Mouse Roche 1:1000 - 1:1000 
GFP Chicken Aves Lab - 1:2000 - 
GSK3β Mouse BD Biosciences 1:2000 - - 
HA (HA.11) Mouse Covance 1:1000 - - 
Nedd4-1 Mouse BD Biosciences 1:500 - - 
Nedd4-2 Rabbit Cell Signaling 1:2000 - - 
NeuN (A60) Mouse Millipore - - 1:100 
MAP2 Rabbit Millipore - - 1:2000 
MAP2 Chicken Novus - 1:2000 1:2000 
MBP Mouse Cell Signaling 1:5000 - - 
c-Myc (9E10) Mouse Sigma 1:1000 - - 
c-Myc Rabbit Santa Cruz 1:1000 - 1:500 
PTEN Rabbit Cell Signaling 1:500 1:250 - 
PTEN (6H2.1) Mouse Millipore 1:500 - - 
β-Tubulin (TUB2.1) Mouse Sigma 1:5000 - - 
phospho-S6 Rabbit Cell 1:2000 - - 




Ubiquitin Rabbit Dako 1:500 - - 
Ubiquitin (P4D1) Mouse Santa Cruz 1:500 - - 
V5 Mouse Cell Signaling 1:500 - - 
WWP1 (0221) Rabbit SySy 1:200 - - 
WWP2 (0217) Rabbit SySy 1:200 - - 
Secondary antibodies used in the present study. 





α-Mouse IgG Goat HRP BioRad WB, 1:20000 
α-Rabbit IgG Goat HRP BioRad WB, 1:20000 
α-Mouse IgG Goat IL-COR IRDye 800 Rockland WB, 1:2000 
α-Rabbit IgG Goat IL-COR IRDye 680 Rockland WB, 1:2000 
α-Chicken IgG Goat Alexa Fluor 488/633 Invitrogen 
IHC/ICC, 
1:1000 
α-Mouse IgG Goat Cy5/ Alexa Fluor 350/488/555 Invitrogen 
IHC/ICC, 
1:1000 
α-Rabbit IgG Goat Alexa Fluor 350/488/555/633 Invitrogen 
IHC/ICC, 
1:1000 
2.3 Molecular Biology 
2.3.1 Bacteria Transformation 
An aliquot (50 µl) of electro-competent E. coli cells was thawed on ice 
and transferred to a pre-cooled electroporation cuvette (0.1 cm, BioRad). 1 µl 
of DNA sample was added to the E. coli cells and mixed gently. The cuvette 
was then applied for an electric pulse of 1.80 kV (E. coli pulser, BioRad). 
Immediately following the electroporation, E. coli cells were retrieved from 
the cuvette with 1 ml LB medium and allowed for recovery for 1 h at 37°C 
under moderate shaking. E. coli cells were then centrifuged at 10,000 g for 1 
min, and the pellet was resuspended in 50 µl LB medium and plated on the 
appropriate selection plates. 
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LB medium:  
25 g Lutia Broth (LB; Invitrogen) powder was dissolved in 1 L distilled H2O 
(ddH2O) and autoclaved. 
LB plates:  
15 g Bacto-agar (Invitrogen) was added in 1 L of LB medium and autoclaved. 
The required selection antibiotic was added after autoclaving. 
2.3.2 Plasmid DNA preparation  
The plasmid DNA preparation was carried out using the PureLink Quick 
Plasmid Miniprep Kit, HiPure Plasmid Midiprep Kit, HiPure Plasmid Maxiprep 
Kit (Invitrogen), or EndoFree Plasmid Maxi Kit (QIAGEN) according to the 
manufacturers' instructions and resuspended in TE buffer.  
TE buffer:  
10 mM Tris-HCl pH 7.4, 1 mM EDTA 
2.3.3 Sequencing of DNA 
All DNA sequence analysis was done in the MPI-EM DNA Core Facility 
on an Applied Biosystems 373 DNA Sequencer. 
2.3.4 Gateway Cloning 
Gateway LR reactions were carried out using the Gateway LR Clonase 
Enzyme Mix (Invitrogen). A reaction mix containing 1 µl entry clone plasmid 
(100-300 ng/µl), 1 µl destination vector (150 ng/µl), 0.5 µl reaction buffer, and 
0.5 µl LR Clonase was prepared and incubated at 25°C overnight. 1 µl of the 
reaction mix was then transformed into E. coli TOP10 competent cells and 
plated on the appropriate antibiotic selection plates. Plasmid DNA from the 
positive E. coli colonies was isolated and subjected to sequencing to confirm 
the sequence. 
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2.3.5 DNA Digestion with Restriction Endonucleases 
The instruction manuals provided  by New England BioLabs were 
referred to for all DNA digestion procedures. Generally, the appropriate 
quantity of DNA was digested for 1-3 h at the enzyme specific temperature in 
the appropriate buffer.  
2.3.6 Agarose Gel Electrophoresis 
For size analyses and purification of DNA, DNA products were 
subjected to agarose gel electrophoresis. Generally, a TBE based-agarose 
gel (0.7-2%) containing ethidium bromide or GelRed was used. Negatively 
charged DNA was separated at a constant current (100-140 mA) in TBE 
buffer and visualized by ethidium bromide or GelRed under UV light 
exposure. GeneRuler DNA Ladder Mix sample (Fermentas) was loaded in 
parallel as the marker. 
TBE buffer:  
50 mM Tris-Base, 50 mM boric acid, 2 mM EDTA, pH 8.0 
2.3.7 Purification of DNA Fragments 
Following the separation by agarose gel electrophoresis, DNA 
fragments of interest were excised and isolated from agarose gels using the 
PureLink Gel Extraction Kit (Invitrogen) according to the manufacturer’s 
protocol.  
2.3.8 De-phosphorylation of 5'-DNA Ends 
Dephosphorylation of the 5'-ends of DNA plasmids with compatible 
ends was carried out in order to prevent the self-ligation of vectors in the 
further DNA ligation procedures. Plasmid DNA was treated with alkaline 
phosphatase (Roche) in the supplied buffer for 15 min at 37°C, according to 
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manufacturer's instructions. The alkaline phosphatase was then inactivated 
by incubation at 65°C for 15 min. 
2.3.9 DNA Ligation 
Plasmid and insert DNA with compatible ends were mixed in a molar 
ratio of 1:1 to 1:10, supplemented with additional 2 mM ATP, T4 DNA ligase 
(Invitrogen), and the ligase-specific buffer in 20 µl of reaction volume. The 
ligation reaction was taken place at 25ºC for 1.5 h, or at 16ºC for 16-20 h. 
2.3.10 Polymerase Chain Reaction (PCR) 
DNA fragments of interest were amplified in 20-25 µl of reaction 
mixtures containing the double stranded DNA template, oligonucleotide 
primers, dNTPs, and pfu DNA polymerase (Stratagene) in the appropriate 
reaction buffer. PCR reactions were run on a Gene Amp 9700 PCR cycler 
(Applied Biosystems) with basic cycle parameters as below: 
Step 1: 94ºC for 2 min 
Step 2: 94ºC for 20 s 
Step 3: annealing temperature for 20 s 
Step 4: 72ºC for extension time (30-40 cycles from Step 2 to Step 4) 
Step 5: 72ºC for 10 min 
Annealing temperatures, extension times, and cycle numbers were 
modified depending on the target DNA. For genotyping PCR, RedTaq DNA 
polymerase (Sigma-Aldrich) was used. 
2.3.11 Site-Directed Mutagenesis 
The QuickChange II Site-Directed Mutagenesis Kit (Stratagene) was 
used according to the manufacturer's instructions with minor modifications. 
Briefly, the primer pair was designed in a fashion that the 5'-end is partially 
overlapped, and the mutation sites are located at the middle of the 
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overlapping region. At least eight non-overlapping bases were introduced at 
the 3'-end of the primer pair. 2 ng of plasmid DNA template was amplified in 
25 µl of reaction mixtures containing oligonucleotide primers, dNTPs, and pfu 
DNA polymerase (Stratagene) in the appropriate reaction buffer. PCR 
reactions were carried out with basic cycle parameters as below: 
Step 1: 94ºC for 3 min 
Step 2: 94ºC for 1 min 
Step 3: annealing temperature for 1 min 
Step 4: 72ºC for extension time (18 cycles from Step 2 to Step 4) 
Step 5: 55ºC for 1 min 
Step 6: 72ºC for 30 min 
Annealing temperatures and extension times were modified depending 
on the target plasmid size. The PCR product was then digested with DpnI 
and transformed into E. coli. Plasmid DNA from the positive E. coli colonies 
was isolated and subjected to sequencing to confirm the mutation. 
2.3.12 Subcloning using the TOPO Cloning Kit 
PCR products were subcloned into the pCRII-TOPO vector using TOPO 
TA cloning Kits (Invitrogen) according to the protocol provided by the 
manufacturer. LB plates containing ampicillin or kanamycin, IPTG, and X-gal 
were used for the blue/white screening. Plasmid DNA from the white colonies 
were isolated and subjected to sequencing to confirm the sequence of insert 
DNA. 
2.3.13 RNA Preparation 
Cultured neurons were harvested at DIV8 with RIPA buffer, and the 
NucleoSpin RNA XS kit (Macherey-Nagel) was used according to the 
manufacturer's instructions. For polysome fractionation and mRNA analysis, 
5×106 neurons were harvested at DIV8 with Lysis buffer [10 mM Tris/HCl pH 
7.5, 10 mM NaCl, 10 mM MgCl2, 1% Triton X-100, 1% deoxycholate, 1 mM 
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DTT, 30 units/ml RNase OUT (Invitrogen) containing 100 µg/ml 
cycloheximide (Sigma-Aldrich 01810), proteinase inhibitors (Sigma-Aldrich 
P8340), phosphatase inhibitor II (Sigma-Aldrich P5726), and phosphatase 
inhibitor III (Sigma-Aldirch P0044)]. After 5 min of incubation on ice, the 
extract was centrifuged for 8 min at 12,000 x g and 4°C. The supernatant 
was loaded onto a 10-60% (w/v) sucrose gradient and sedimented by 
centrifugation at 4°C for 150 min at 169,000 x g in a Beckman SW41 rotor. 
RIPA buffer: 
50 mM Tris-HCl (pH 7.5 at 4°C), 1 mM EDTA, 150 mM NaCl, 1% Triton X-
100, 0.1% SDS 
Lysis buffer: 
10 mM Tris-HCl (pH 7.5 at 4°C), 10 mM NaCl, 10 mM MgCl2, 1% Triton X-
100, 1% deoxycholate, 1 mM DTT, 30 units/ml RNase OUT (Invitrogen), 100 
µg/ml cycloheximide (Sigma-Aldrich 01810), proteinase inhibitors (Sigma-
Aldrich P8340), phosphatase inhibitor II (Sigma-Aldrich P5726), and 
phosphatase inhibitor III (Sigma-Aldrich P0044) 
2.3.14  Real Time Quantitative-PCR (RT-qPCR) 
For the total mRNAs quantity study, 150 ng of the total RNA were 
subjected to one cycle of retrotranscription in a mixture of random nonamer 
primers, anchored poly-dT primers, and the SuperScript III RNase H reverse 
transcriptase (Invitrogen) according to the manufacturer's instructions. Real-
time PCR (RT-qPCR) was carried out with the SYBR Green PCR master mix 
(Applied Biosystems), cDNAs, and the gene specific primers. Samples were 
analyzed using the 7500 Fast Real-Time PCR System (Applied Biosystems). 
The input concentration of cDNAs was optimized to ensure that the detection 
was within the linear range. Relative levels of mRNAs of interest were 
normalized to the levels of two house-keeping mRNAs, Rpl13a and ATP5b. 
For the RNA analysis (mRNA translation) after polysome fractionation, 
each gradient was collected into 12 fractions followed by the addition of 1% 
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SDS (final concentration), 40 pg of exogenous (in vitro transcribed) BC200 
RNAs, 10 mg glycogen, and proteinase K (50 µg/ml), and incubated for 30 
min at 37°C. The exogenous human BC200 RNA (different sequences from 
the rodent BC1 RNA) was used to monitor possible RNA loss from each 
fraction during RNA phenol/chloroform extraction and precipitation. RNAs 
were precipitated with 0.2 M NaOAc and 0.7 volume of isopropanol. Pellets 
were then re-suspended in 10 µl of ddH2O. The RNA fractions 1-7 
(polysomal fraction, P) and 1-12 (total RNA) were pooled. Following the in 
vitro retrotranscription the real-time PCR was performed. The translational 
efficiency was calculated as follows: 2–[ΔCt(P)–ΔCt(Total)] = 2–ΔΔCt, where ΔCt 
equals Ct (specific mRNAs) – Ct (BC200 RNA). 
2.3.15 Cloning Strategies for Constructs Generated in This Study 
pCRII TOPO-p25 
The cDNA fragment encoding human p25 was amplified by PCR from the 
pGEX6P-2-p35 vector using primers 28606/28607 and subcloned into the 
pCRII-TOPO vector. 
pCIneoHA-p25 
The p25 cDNA was excised from the pCRII-TOPO-p25 vector using 
EcoRI/XhoI and ligated to the EcoRI/SalI sites of pCIneoHA vector. 
pCIneoMyc-Cdk5 
The full length Cdk5 WT cDNA was excised from the pRaichuMyc-Cdk5 WT 
vectors using EcoRI/NotI and ligated to the corresponding sites of 
pCIneoMyc vector. 
pcDNA3.1nMyc-DEST 
Primers 30937/30938 were used to compose the cDNA encoding the Myc-
tag with a N-terminal HindIII site. The cDNA fragment was then digested with 
HindIII and ligated into the pDNA3.1nV5-DEST vector with the V5 cDNA 
fragment excised using HindIII/EcoRV. 







cDNAs from the corresponding Gateway entry vectors were transferred to 
the Gateway destination vector pcDNA3.1nMyc-DEST after LR reactions 
using the Gateway cloning method.  
pGEX4T-1-WWP1 C886S 
The C-terminal WWP1 C886S cDNA fragment was excised from the 
pCIneoMyc-WWP1 C886S vector using XhoI/NotI and ligated to the 
pGEX4T-1-WWP1 WT vector with the C-terminal WWP1 WT cDNA fragment 
excised using XhoI/NotI. 
pGEX6P-1-Cdk5 WT 
The full length Cdk5 WT cDNA fragment was excised from the pRaichuMyc-
Cdk5 WT vector using EcoRI/XhoI and ligated to the corresponding sites of 
GEX6P-1 vector. 
pGEX6P-1-Cdk5 P234A, Y236F 
Primers 31918/31919 were used to generate the pGEX6P-1-Cdk5 P234A, 
Y236F vector using the Quick Change site-directed mutagenesis method. 
pCRII-TOPO-Myc-Cdk5 
The cDNA encoding a N-terminal Myc-tagged Cdk5 WT was amplified by 
PCR using primers 27283/30007 from the pCIneoMyc-Cdk5 WT vector and 
subcloned into the pCRII-TOPO vector. 
pRRLsinPPT-CMV-WPRE-Myc-Cdk5 WT 
The N-terminal Myc-tagged Cdk5 WT cDNA fragment were excised from the 
pCRII-TOPO-Myc-Cdk5 WT vector using BamHI, and ligated to the BamHI 
site of pRRLsinPPT-CMV-WPRE vector. 
 




The p25 cDNA was excised from the pCRII-TOPO-p25 vector using 
EcoRI/XhoI and ligated to the EcoRI/SalI sites of pMalC2 vector. 
pFUGW-WWP2 WT 
The full length WWP2 cDNA was excised from the pCRII-TOPO-WWP2 WT 
vector using SpeI/XbaI, and ligated into the pFUGW vector with the EGFP 
cDNA fragment excised by XbaI. 
pFUGW-WWP1 WT 
The full length WWP1 cDNA was excised from the pCIneoMyc-WWP1 WT 
vector using EcoRI/MfeI, and ligated into the pFUGW-WWP2 WT vector with 
the WWP2 WT cDNA excised by EcoRI. 
2.4 Biochemistry 
2.4.1 Determination of Protein Concentration 
To quantify the protein concentration, the bicinchoninic acid (BCA) 
method was employed according to the manufacturer's instructions (Thermo 
Scientific). Briefly, protein samples were incubated with the BCA regents at 
37°C for 30 min and the absorbance at 652 nm of each sample was 
measured. The standard BSA samples with known concentration were 
referred to in order to estimate the protein concentration of each sample. 
2.4.2 Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
To separate proteins based on their molecular sizes, protein samples 
were subjected to SDS-PAGE under the denatured condition. Briefly, protein 
samples were dissolved in Laemmili buffer, followed by boiling at 95ºC for 3 
min. The SDS-PAGE gel consisting of the upper part stacking gel and the 
lower part resolving gel (see recipes below) was prepared and set on the 
Bio-Rad Mini-PTOTEAN 251 casting system. Protein samples were loaded 
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onto the gel and electrophoresis was performed with a constant current of 20 
mA for samples in the stacking gel and 30-40 mA for samples in the 
resolving gel. Generally, 5-20 µg of protein was loaded alongside an SDS-
PAGE ladder (Invitrogen). 
Laemmili Buffer: 
10% Glycerol, 50 mM Tris-HCl (pH 6.8 at RT), 2 mM EDTA, 2% SDS, 100 
mM DTT, 0.05% Bromophenol blue. 
Upper stacking gel: 
5% acrylamide/N,N'-Methylene-bis-Acrylamide (29:1) Solution (AMBA), 125 
mM Tris-HCl (pH 6.8 at RT), 0.1% SDS, 0.05% ammonium persulfate (APS), 
0.005% TEMED. 
Lower resolving gel: 
8-15% AMBA, 325 mM Tris-HCl (pH 8.8), 0.1% SDS, 0.05% APS, 0.005% 
TEMED. 
Running buffer: 
25 mM Tris-HCl, 250 mM Glycine, 0.1% SDS (pH 8.8). 
2.4.3 Western Blotting 
Proteins separated by SDS-PAGE were electrically transferred to PVDF 
or nitrocellulose membranes. Non-specific binding of antibodies to the 
membranes was pre-blocked by incubation with 5% skimmed milk in TBST 
containing 5% goat serum. Subsequently, the membranes were incubated 
with primary antibodies, followed by incubation with the corresponding 
secondary antibodies diluted in 5% skimmed milk in TBST. Signals were 
detected with the enhanced chemiluminescence (ECL) system (GE 
Healthcare), or the Odyssey Infrared Imaging System (Li-COR Biosciences). 
Quantification was done by using the Odyssey software, the Bio-Rad 
ChemiDoc system, or ImageJ. 
 




20 mM Tris-HCl (pH 7.5 at RT), 137 mM NaCl, 1% Tween20 (w/v). 
2.4.4 Purification of Recombinant GST-Fusion Proteins 
The GST gene fusion system (GE Healthcare Life Sciences) was 
employed to purify GST-fusion proteins. cDNA fragments encoding the full-
length WWP1 WT, WWP1 C886S, WWP2 WT, Cdk5 WT, and Cdk5 
P236A/Y238F were subcloned into pGEX-4T-1 or pGEX-6P-1 vectors, which 
were then back-transformed into the BL21 Rossetta E. coli strain. A single 
colony was inoculated in 50 ml LB medium in the presence of ampicillin 
(LB+Amp) and pre-cultured at 37°C overnight. The pre-culture was then 
transferred into 1000 ml of LB+Amp medium and stirred at 17°C to allow for 
E. coli growth. When the optical density at 600 nm (OD600) of the E.coli 
culture reached 0.5-0.6, expression of the GST-fusion proteins were induced 
by the addition of 0.1 mM isopropyl-β-D-1-thiogalactopyranoside (IPTG). E. 
coli cells were harvested by centrifugation at 3500 x g at 4°C for 30 min when 
the OD600 reached 0.9-1.0. The pellet was then resuspended in 50 ml Lysis 
buffer and evenly distributed into ten aliquots. The aliquots were flash frozen 
in liquid nitrogen and stored at -80°C until further purification steps. 
For further purification of the GST-fusion proteins, bacteria aliquots 
were thawed in Lysis buffer and supplemented with protease inhibitors (0.2 
mM PMSF, 1 µg/ml Aprotinin, 0.5 µg/ml Leupeptin), lysozyme (1 mg/ml), 
DNase I (50 µg/ml), MgCl2 (1 mM) and DTT (1 mM). After 10 min incubation 
on ice, the cells were sonicated for 20 s for three times with 1 min interval of 
incubation on ice, followed by the addition of 0.8% CHAPS to solubilize the 
proteins. After 30 min incubation on ice with gentle agitation, insoluble 
fractions were removed by centrifugation at 10,000 x g for 15 min at 4°C. The 
GST-fusion proteins were affinity-purified by incubation with the reduced 
glutathione (GSH) covalently coupled to sepharose 4B beads (GE 
Healthcare) according to the manufacturer's instructions. The bound fractions 
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of GST-fusion proteins were then eluted with 40 mM reduced GSH or 
incubated with thrombin or prescission protease to remove the GST tag. 
Lysis buffer A (for GST-WWP1 WT, GST-WWP1 C886S, GST-WWP2 WT): 
20 mM Tris-HCl (pH 7.5 at 4°C), 150 mM NaCl, 1 mM EDTA, 1 mM DTT 
Lysis buffer B (for GST-Cdk5 WT, GST-Cdk5 P234A,Y236F): 
20 mM MOPS (pH 7.5 at 4°C), 150 mM NaCl, 1 mM EDTA, 1 mM DTT 
2.4.5 Affinity Purification of GST-WWP1 Binding Proteins 
The recombinant GST-WWP1 WT was purified from E. coli and 50 µg 
of the purified GST-WWP1 WT was immobilized on 50 µl glutathione 
sepharose 4B beads (GE Healthcare Life Sciences). After washing the beads 
for three times with five bed volumes of A-buffer, a 0.8% CHAPS extract (in 
A-Buffer) of mouse brain synaptosomes was loaded to the beads, which 
were then washed for three times with five bed volumes of A-buffer. 
Subsequently, the GST-WWP1 binding proteins were eluted with B-buffer 
(same composition as A-buffer except for 1 M NaCl), followed by elution with 
A-buffer containing 40 mM glutathione. 
A-buffer: 
20 mM Tris-HCl (pH 7.5 at 4°C), 0.32 M Sucrose, 1 mM EDTA, 1 mM DTT, 
and 1% Triton X-100, 150 mM NaCl, 0.2 mM PMSF, 1 µg/ml Aprotinin, 0.5 
µg/ml Leupeptin. 
B-buffer: 
20 mM Tris-HCl (pH 7.5 at 4°C), 0.32 M Sucrose, 1 mM EDTA, 1 mM DTT, 
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2.4.6 Protein Identification by Mass Spectrometry 
Proteins eluted from the GST-WWP1 beads were separated by SDS-
PAGE under the reduced condition on a pre-cast NuPAGE 4%-10% Bis-Tris 
gradient gel (Invitrogen) using a MOPS-based buffer system recommended 
by the manufacturer. Eluates from GST beads and GST-WWP1 beads with 
only buffer input were used as negative controls. After colloidal Coomassie 
staining, gel plugs were manually excised from individual bands that are 
specifically enriched in the eluates from GST-WWP1 beads with brain lysates 
input. Proteins in the gel were then extracted, trypsinized, and subjected to 
an automated platform for the identification of peptides using mass 
spectrometry as described previously (Jahn et al., 2006; Reumann et al., 
2007; Werner et al., 2007). An Ultraflex MALDI-TOF-mass spectrometer 
(Bruker Daltonics) was used to acquire both peptide mass fingerprint and 
fragment ion spectra, resulting in confident peptide identifications based on 
the mass and the sequence information. The resulting information was then 
analyzed by Mascot software (Matrix Science) to match the peptide 
sequences with Swiss-prot and NCBI databases (Taxonomy: Mouse) using 
the parameter settings described earlier (Jahn et al., 2006; Reumann et al., 
2007; Werner et al., 2007). Only the proteins identified with high confidence 
in both databases were taken into account as potential binding partners of 
WWP1. 
2.4.7 In Vitro Binding Assay 
50 µg of recombinant GST-WWP1 WT and GST-WWP2 WT, or 45 µg 
of GST-Cdk5 WT and GST-Cdk5 P234A/Y236F were purified from E. coli 
and immobilized on 50 µl of glutathione sepharose 4B beads (GE Healthcare 
Life Sciences) in columns. Proteins of interest were purified from HEK293FT 
cells or E. coli and loaded to the columns. After extensively washing of the 
columns with the corresponding binding buffer, the beads were collected and 
subjected to Western blotting analysis. 
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Binding buffer A:  
20 mM Tris-HCl (pH 7.5 at 4°C), 150 mM NaCl, 1 mM EDTA, 0.32 M 
Sucrose, 0.8% CHAPS, 1 mM DTT, 0.2 mM PMSF, 1 µg/ml Aprotinin, 0.5 
µg/ml Leupeptin. 
Binding buffer B (for Cdk5):  
20 mM MOPS (pH 7.5 at 4°C), 150 mM NaCl, 1 mM EDTA, 1 mM DTT, 0.2 
mM PMSF, 1 µg/ml Aprotinin, 0.5 µg/ml Leupeptin. 
2.4.8 In Vitro Ubiquitination Assay  
The in vitro ubiquitination reactions were carried out in 20 µl of the 
reaction mixture containing 2 mM ATP, 1 µg ubiquitin (Boston Biochem), 20 
ng UBE1 (Boston Biochem), 200 ng of each E2 (UbcH5b, UbcH6, and 
UbcH7; Boston Biochem), 250 ng of the recombinant E3 purified from E. coli 
(WWP1 WT, WWP1 C886S or WWP2 WT), and 100-400 ng of the substrate 
of interest (either purified from E.coli or immunopurified from transfected 
HEK293FT cells) in a Tris-based buffer [50 mM Tris-HCl (pH 8.0 at 25°C), 
150 mM NaCl, 10 mM MgCl2], and incubated at 37°C for 1 h with gentle 
agitation. Reactions were then stopped by the addition of Laemmili buffer, 
and the results were analyzed by Western blotting. 
2.4.9 Immunoprecipitation (IP) 
For anti-Myc IP, agarose beads conjugated with the anti-Myc antibody 
(Sigma-Aldrich) were used. For IP of other proteins, Protein A sepharose CL-
4B beads (GE Healthcare) were incubated with 10% BSA for 30 min at RT, 
followed by washing twice with PBS and equilibrating in the corresponding 
lysis buffer containing appropriate detergent(s). Antibody-antigen complexes 
were bound to Protein A sepharose CL-4B beads at 4°C. After extensively 
washing the beads with lysis buffer, proteins were eluted by boiling in 
Laemmli buffer, followed by SDS-PAGE and analysis of the results using 
Western blotting. For immunoprecipitation of proteins under denaturing 
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conditions, proteins were extracted with lysis buffer containing 1% SDS, 
boiled for 5 min, and the SDS was neutralized with lysis buffer containing 1% 
TritonX-100. 
2.4.10 In Vivo Ubiquitination Assay 
Mammalian expression vector for Myc-Cdk5 was co-transfected with 
WWP1 WT or WWP2 WT expression vectors and either HA-ubiquitin WT, 
ubiquitin K48R, or ubiquitin K63R expression vectors using Lipofectamin2000 
(Invitrogen). Cells were harvested in A-buffer containing 0.5% SDS and the 
lysates were boiled for 5 min, followed by neutralizing the SDS by diluting 
five times with A-buffer containing 1% TritonX-100. Myc-Cdk5 was then 
immuoprecipitated using the anti-Myc agarose beads (Sigma-Aldrich). After 
extensively washing the beads with lysis buffer containing 1% TritonX-100, 
the immuoprecipitated Myc-Cdk5 was subjected to SDS-PAGE, followed by 
Western blotting to HA or ubiquitin. 
A-buffer:  
20 mM Tris-HCl (pH7.5 at 4°C), 150 mM NaCl, 1 mM EDTA, 0.2 mM PMSF, 
1 µg/ml Aprotinin, 0.5 µg/ml Leupeptin, 10 mM NEM, 20 mM Indoacetamide. 
2.4.11 PTEN Phosphatase Activity Assay 
PTEN was immunoprecipitated from P7 mouse brains in lysis buffer. 
The activity of the immunoprecitated PTEN was assessed using a 
commercially available phosphatase assay kit (K-1500, Echelon) according 
to the manufacturer's instructions. Briefly, protein A sepharose CL-4B beads 
with immunoprecipitated PTEN were washed with reaction buffer. Enzyme 
reactions were carried out by incubating PTEN with 120 µM of water soluble 
PtdInsP3 (diC8, Echelon) in the PTEN reaction buffer for 40 min at 37°C. Free 
phosphate generated was detected by the Malachite Green reagent supplied 
in the kit in a colorimetric manner. Absorbance at 650 nm was measured and 
the free phosphate level (pmol) was calculated using a phosphate standard. 
	   Materials and Methods	  
42	  
	  
The percentage of PtdInsP3 conversion was calculated according to the 
following formula: % PtdInsP3 conversion = {[(free phosphates in reaction, 
pmol) – (background phosphate in substrate only control, pmol)] ÷ (input 
PtdInsP3, pmol)} × 100%. 
Lysis buffer: 
25 mM Tris/HCl pH 8.0, 150 mM NaCl, 1% TritonX-100, 1 mM EDTA, 0.2 
mM PMSF, 1 µg/ml Aprotinin, 0.5 µg/ml Leupeptin. 
Reaction buffer: 
25 mM Tris/HCl pH 7.5, 140 mM NaCl, 2.7 mM KCl, 10 mM DTT. 
2.5 Cell Biology 
2.5.1 Culture Media and Solutions 
10% FCS/DMEM: 
500 ml DMEM, 50 ml FCS, Glutamine (Invitrogen), 5 ml 
Penicillin/Streptomycin (100x, Invitrogen). 
Complete Neurobasal medium: 
500 ml Neurobasal A, 5 ml GlutaMAX I (Invitrogen), 10 ml B-27 supplement 
(Invitrogen), 1 ml Penicillin/Streptomycin (100x, Invitrogen). 
Papain solution: 
20-25 units of Papain per 1 ml of solution 1 were added and bubbled with 
carbogen (95% oxygen, 5% carbon dioxide) for 10-20 min until the solution 
becomes clear. The Papain Solution was sterilized using a 0.22 µm filter 
(Millipore) and kept on the ice before use. 
Stop solution: 
2.5 mg/ml BSA, 2.5 mg/ml trypsin inhibitor, and 10% FCS in DMEM. The 
solution was pre-warmed at 37°C before use. 
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2.5.2 Primary Mouse Hippocampal Culture Preparation 
Hippocampi from P0 mice were isolated and digested in 25 units/ml of 
papain (Worthington Biochemical) in papain solution at 37°C for 1 h, followed 
by incubation in stop solution at 37°C for 15 min. The papain digested 
hippocampi were then mechanically triturated with a plastic tip for P-200 
Pipetman in 200 µl of the pre-warmed complete Neurobasal medium. The 
dissociated neurons were plated on poly-L-lysine (Sigma-Aldrich) coated 
coverslips at a density of 30,000-60,000 cells per cm2. Neurons were 
cultured in the complete Neurobasal medium at 37°C in a cell culture 
incubator with 5% CO2 (Thermo) before harvesting or fixation. 
2.5.3 Transfection of Primary Hippocampal Culture 
Cultured hippocampal neurons were transfected by the calcium 
phosphate method at DIV1. Briefly, the culture medium in each well of the 
24-well plate was replaced with 500 µl of pre-warmed Opti-MEM I 
(Invitrogen) 30 min before transfection. 45 µl of Transfection mixture 
containing 3 µg of DNA and 25 mM CaCl2 was prepared in a 1.5 ml 
eppendorf, and 45 µl of 2x HBS was added to the mixture drop-wisely with 
gentle shake. After incubation at room temperature for at least 20 min, 30 µl 
of the mixture was applied to each well of the 24-well plate. The neurons 
were incubated in a 37°C/5% CO2 incubator for 25 min, followed by removing 
the calcium phosphate precipitates by washing with the Neurobasal A 
medium pre-equilibrated in a 37°C/10% CO2 incubator. The neurons were 
further cultured in the complete Neurobasal medium at 37°C in a cell culture 
incubator with 5% CO2 before harvesting or fixation. 
2× HBS: 
274 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4, 15 mM glucose, 42 mM 
HEPES (Sigma, H3375, pH 7.08 adjusted by NaOH). Aliquots were stored at 
-20°C. 
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2.5.4 HEK293FT Cell Line 
HEK293FT cells were maintained in tissue culture dishes with 10% 
FCS/DMEM in the 37°C/5% CO2 incubator. Transfection of HEK293FT cells 
was done by using Lipofectamine2000 (Invitrogen) according to the 
manufacturer's instructions. 
2.5.5 Lentivirus Preparation 
1.6×107 HEK293FT cells (Invitrogen) were plated on a poly-L-Lysine 
(Sigma-Aldrich) coated 15-cm plastic dish and cultured for 24 h in OPTI-
MEM medium (Gibco) containing 10% fetal calf serum (PAA). The packaging 
vector pCMVdeltaR8.2, the VSV-G expression vector pMD2.G, and the 
backbone vector were co-transfected to HEK293FT cells with 
Lipofectamine2000 (Invitrogen) according to the manufacturer's instructions. 
Cells were incubated for 18 h, and afterwards the medium was changed to 
Dulbecco's modified Eagle medium (Gibco) containing 2% fetal calf serum 
(PAA), 10 units/ml penicillin, 10 µg/ml streptomycin (Gibco), and 10 mM 
sodium butyrate (Merck). The culture medium, which contained lentiviral 
particles, was harvested 72 h after transfection. To increase the viral titer, 
Amicon Centrifugal Filters (100 kDa, Millipore) were used according to the 
manufacturer's instructions to concentrate viral particles. The high-titer 
lentivirus sample was then dialyzed with dialysis buffer overnight, flash 
frozen with liquid nitrogen, and stored in -80°C until used. 
Dialysis buffer: 
20 mM Tris/HCl pH 8.0 at 4°C, 150 mM NaCl 
2.5.6 Immunocytochemistry (ICC) 
Cells cultured on the coverslips were fixed with 4% paraformaldehyde 
(w/v)/PBS at 4°C for 20 minutes. After washing with PBS for three times, the 
cells were incubated with blocking buffer at room temperature for 1 h, 
followed by incubation with primary antibodies diluted in blocking buffer at 
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4°C overnight. Subsequently, cells were washed three times with PBS and 
incubated with the corresponding fluorescently-labeled secondary antibodies 
diluted in blocking buffer at room temperature for 2 h. After washing the cells 
with PBS for three times and once with ddH2O, coverslips were air-dried and 
mounted on the microscope glass slide with the mounting medium (Thermo 
Scientific). 
Blocking buffer: 
PBS containing 10% Horse serum, 2% BSA, 5% (w/v) Sucrose, 0.3% (w/v) 
TritonX-100 
2.6 Histology 
2.6.1 In Utero Electroporation 
At embryonic stage 15.5 (E15.5), plasmid DNA was transfected to a 
subpopulation of neuronal progenitor cells, which generate mainly layer II/III 
cortical neurons. The electroporated brains were fixed at P21, when the 
axons of layer II/III cortical neurons have reached the contralateral side 
(callosal projections) and branched extensively into the somatosensory 
cortex. Pregnant mice were deeply anesthetized with isoflurane and placed 
on a warming pad (31-32°C) throughout the surgery. An approximately 2-cm 
midline incision in the abdomen was made, and uterine horns were drawn 
out through the incision and moistened with warmed PBS containing 
antibiotics (Penicillin-Streptomycin, Sigma-Aldrich). Plasmid DNA solution 
prepared with the EndoFree Plasmid Maxi Kit (Qiagen) was injected into the 
lateral ventricle through a glass micropipette, and electric pulses (35 V, 50 
mA, 50 ms duration, 950 ms intervals, 8 pulses per embryo) were applied 
with the ECM830 electroporator (BTX Harvard Apparatus). The incision was 
then closed with surgical sutures. Animals were kept warm (31-32°C) until 
they had recovered from anesthesia. 
 




For histological experiments using mouse brains, mice were perfused 
transcardially with PBS, followed by 4% paraformaldehyde (w/v)/PBS. The 
brains were then taken out and post-fixed in 4% paraformaldehyde (w/v)/PBS 
at 4°C overnight. After washing twice with PBS, the brains were subjected to 
further histological experiments. 
2.6.3 Immunohistochemistry (IHC) 
Paraffin embedded mouse brain coronal sections were used for the 
anti-NeuN staining. Paraffin sections (5 µm) were collected on glass slides. 
After de-paraffination, sections were incubated in blocking buffer (20% goat 
serum in 10% BSA/PBS), and subsequently incubated with primary 
antibodies at 4°C overnight, followed by incubation with the corresponding 
fluorescently-labeled secondary antibodies. Images were acquired on an 
Olympus BX61 microscope. Numbers of cells were counted manually by a 
blind observer with the help of the 'Cell Counter' plugin in ImageJ. For 
analyses of axon morphogenesis in vivo, immunostaining of 100 µm floating 
vibratome sections was performed. Brain sections were blocked with 
blocking buffer (5% goat serum, 0.1% Triton X-100 in PBS), followed by 
incubation with chicken anti-GFP (Aves Lab), rabbit anti-Cux1 (Santa Cruz), 
and mouse anti-Cre (Sigma-Aldrich) antibodies that had been diluted in the 
same buffer. The sections were then incubated with fluorescently labeled 
secondary antibodies diluted in 2% goat serum/PBS. 
2.7 Image Analysis and Statistic 
To study the outgrowth of axons, neurons were transfected with an 
EGFP expression vector at DIV1, fixed at DIV7, immunostained for GFP (7.1 
and 13.1, Roche), and pictures of EGFP-expressing neurons were acquired 
with a 10x objective on an Olympus BX61 fluorescence microscope. 
Analyses were performed using the NeuronJ plugin in ImageJ (NIH). The 
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longest neurite was taken as the axon, and the branch number was 
determined by counting the number of neurites (>15 µm) extending from the 
longest neurite. For studies on the intracellular localization of PTEN, neurons 
were fixed at DIV7 and subjected to immunostaining for PTEN. The 
fluorescence staining was imaged with a 63× objective lens on a Leica 
confocal microscope (TCS SP2 equipped with AOBS). The mean intensity of 
PTEN signals was scored using ImageJ. Nuclei were defined by DAPI 
staining, and the dimension of neuronal somata was determined manually. 
For analyses of neuronal cell polarity, AnkyrinG-positive but MAP2-negative 
neurites were scored as axons. For Sholl analysis of neurite structure, 
neurons were transfected with an EGFP expression vector at DIV1. The 
neurons were then treated with 20 nM rapamycin (Cell Signaling) or DMSO 
at DIV6 and fixed at DIV10. The 'Advanced Sholl Analysis' plugin in ImageJ 
was used for analysis, in which concentric circles were drawn at 7.5 µm 
intervals using the cell body as the common center, and the numbers of 
neurites crossing each of the circles were counted. For all of the 
morphological analyses on cultured neurons, neurons were chosen because 
they are healthy, with continuous and extended neurites. Inclusion of 
neurons with neurites circling around the soma was avoided, since this 
morphology complicates the analysis. Acquisition and analyses of images 
were done by a blind observer. 
For quantification of axon branching in vivo, fluorescence images were 
acquired on a Leica SP2 confocal microscope. For each brain section, a z-
stack serial scan for 10 images at 2.5 µm intervals was performed at the 
approximate level of 0.26 mm from the bregma. Images taken from the 
somatosensory cortex at the contralateral side were then projected to two 
dimensions using the maximum intensity projection function of the Leica 
confocal software. Signals from the cortical surface (cortical level set as 1) to 
the bottom of the white matter (cortical level set as 0) were quantified using 
the 'plot profile' function in ImageJ. Fluorescence intensity was normalized to 
the maximum value in the white matter to compensate for the variability in 
numbers of afferent axons originating from the transfected neurons. The 
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normalized maximum values from the upper layer (cortical level 0.7-1) and 
the lower layer (cortical level 0.25-0.69) of the cortex were subjected to 
statistical analyses. 
Statistical analyses were done using the Graphpad Prism 5 (Graphpad 
Software). A statistical significant difference was concluded when the p-value 
was less than 0.05. The following annotations were used in the present study 









3.1 Ubiquitin E3 Ligase Nedd4-1 Acts as a Downstream 
Target of PI3K/PTEN-mTORC1 Signaling to Promote 
Neurite Growth (Hsia et al., 2014) 
3.1.1 KO of Nedd4-1 and Nedd4-2 Causes Defects in Axonal Growth 
Mammalian Nedd4-1 promotes the growth and arborization of dendrites 
by monoubiquitinating Rap2 (Kawabe et al., 2010). In an independent study, 
Xenopus laevis Nedd4, which is most homologous to mammalian Nedd4-2, 
was reported to control axonal branching in retinal ganglion cells by 
polyubiquitinating PTEN (Drinjakovic et al., 2010). Consistent with the latter 
study, I found that deletion of Nedd4-2 in cultured hippocampal neurons 
resulted in reduced neurite complexity (Figure 3-1). In order to avoid possible 
compensation of the functions of Nedd4-1 by Nedd4-2 and to study the roles 
of Nedd4-1/Nedd4-2 in axonal development in mammalian neurons, I 
characterized postmitotic neuron-specific Nedd4-1 and Nedd4-2 conditional 
double KO mice (NEX-Cre;Nedd4-1f/f;Nedd4-2f/f, NEX-N1/2f/f). The NEX-
N1/2f/f mice are viable and show no obvious behavioral alterations in the cage 
environment. However, macroanatomical analyses of developing NEX-N1/2f/f 
mouse brains at postnatal day 16 (P16) showed a reduction in the thickness 
of the cortex while the total number of neurons was not changed (Figure 3-2). 
Therefore, this reduction is likely caused by the reduced length of dendrites 
that was reported previously (Kawabe et al., 2010).  
To study the roles of Nedd4-1 and Nedd4-2 in axon morphogenesis in 
vitro, I prepared primary cultured hippocampal neurons from control or NEX-
N1/2f/f mice and transfected them with an EGFP expressing vector to 
visualize neurite structures. At day-in-vitro 7 (DIV7), the length of the main 
axon shaft and the number of primary axonal branches showed a significant 
reduction in cultured NEX-N1/2f/f neurons relative to controls (Figure 3-3 A-
C). In an independent set of experiment, I characterized the axonal 
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morphology of cultured hippocampal neurons prepared from NEX-Cre WT or 
NEX-Cre heterozygote (Het) mice (Figure 3-3 D-F). No difference in the 
axonal morphology was observed between these two groups, indicating that 
NEX-Cre expression itself does not affect axon morphogenesis and the 
reduced axonal growth of NEX-N1/2f/f neurons (Figure 3-3 A-C) is a specific 
outcome of Nedd4-1 and Nedd4-2 deletion. 
 
Figure 3-1. Nedd4-2 Regulates Neurite Growth in Mouse Hippocampal 
Neurons 
(A and B) Representative images of control (A) and Nedd4-2 KO (B) cultured 
hippocampal neurons transfected with an EGFP expressing vector. Scale 
bars, 50 µm. (C) Sholl analyses for the two groups in (A) and (B). Note that 
KO of Nedd4-2 slightly reduced neurite growth. (D) Statistical analysis of the 
total number of crossing neurites obtained in the Sholl analysis shown in (C). 
Nedd4-2f/f, N=87; NEX-Cre;Nedd4-2f/f, N=73. *p=0.0433, unpaired t test. 
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Figure 3-2. Reduced Thickness of Cortices in NEX-Cre;Nedd4-
1f/f;Nedd4-2f/f Mouse Brains 
(A) Anatomical studies on Nedd4-1f/f;Nedd4-2f/f (left) and NEX-Cre;Nedd4-
1f/f;Nedd4-2f/f (right) mouse brains at P16. 5 µm-thick brain paraffin sections 
were immunostained with an anti-NeuN antibody. Note that the thickness of 
the cortex was reduced in the NEX-Cre;Nedd4-1f/f;Nedd4-2f/f brain. Scale 
bars, 500 µm. (B) High-magnification images of the cortices shown in (A) 
revealed a reduction in thickness of cortex in the NEX-Cre;Nedd4-1f/f;Nedd4-
2f/f brains (right). Scale bars, 50 µm. (C) Reduced thickness of the cortex in 
the NEX-Cre;Nedd4-1f/f;Nedd4-2f/f brain (1.157±0.0173 mm, N=11 slices from 
4 animals) as compared to the control Nedd4-1f/f;Nedd4-2f/f brain 
(1.459±0.0245 mm, N=8 slices from 4 animals). ***p<0.0001, unpaired t test. 
(D) The number of neurons in a cortical region with the width of 100 µm. No 
significant difference in the number of neurons was observed between the 
two groups. Nedd4-1f/f;Nedd4-2f/f, 142±2, N=8 slices from 4 animals; NEX-
Cre;Nedd4-1f/f;Nedd4-2f/f, 140±5, N=11 slices from 4 animals. Data are 
expressed as mean±SEM. 
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Figure 3-3. Nedd4-1 and Nedd4-2 Regulate Axon Growth in Mouse 
Hippocampal Neurons in vitro 
(A) Representative images of control (left) and Nedd4-1 and Nedd4-2 double 
KO (right) cultured hippocampal neurons transfected with an EGFP 
expressing vector. Scale bars, 100 µm. (B) Reduced length of main axon 
shafts in Nedd4-1;Nedd4-2 double KO neurons. N1/2f/f, 0.99±0.033 mm, 
N=92; NEX-N1/2f/f, 0.84±0.035 mm, N=81. **p=0.0026, unpaired t test. (C) 
Reduced number of primary axonal branches in Nedd4-1;Nedd4-2 double 
KO neurons. N1/2f/f, 11±0.5, N=92; NEX-N1/2f/f, 8±0.4, N=81. ***p<0.0001, 
unpaired t test. (D) Representative images of NEX-Cre wildtype (WT, left) 
and NEX-Cre heterozygote (Het, right) cultured hippocampal neurons 
transfected with an EGFP expressing vector. Scale bars, 100 µm. (E and F) 
No difference in length of main axon shafts (E) and in number of primary 
axonal branches (F) in NEX-Cre Het neurons as compared to NEX-Cre WT 
neurons are detectable, indicating that the phenotypic change observed in 
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I further performed in utero electroporation to study the roles of Nedd4-
1 and Nedd4-2 in axonal morphogenesis in vivo. At embryonic stage 15.5 
(E15.5), plasmid DNA was transfected to a subpopulation of neuronal 
progenitor cells, which generate mainly layer II/III cortical neurons that 
project axons to the contralateral cortex (callosal projections). The axonal 
morphology of neurons was visualized by overexpressing a membrane-
anchored variant of the Venus yellow fluorescent protein (myrVenus), and 
Nedd4-1/Nedd4-2 were eliminated by co-expression of Cre in Nedd4-
1f/f;Nedd4-2f/f embryos. The brains were fixed at P21, when the axons of 
upper layer cortical neurons have reached the contralateral side and 
branched extensively into the somatosensory cortex. Most of the myrVenus-
expressing neurons migrated properly to the upper cortical layers of the 
ipsilateral side independently of the Cre expression (Figure 3-4A), indicating 
that Nedd4-1 and Nedd4-2 are dispensable for neuronal migration (see also 
Figures 3-2 A and B). Both control and Nedd4-1;Nedd4-2 KO neurons 
projected axons to the contralateral side of the cortex, but the extent of axon 
invasion as assessed by myrVenus signal intensity was lower with Nedd4-
1;Nedd4-2 KO neurons (Figures 3-4 A and B). Callosal axons branched 
specifically in layers II/III and V on the contralateral side (Figure 3-4B) 
Interestingly, we observed a significant reduction of axonal branching in Cre-
expressing Nedd4-1;Nedd4-2 KO neurons (Figures 3-4 C and D). Taken 
together, these in vitro and in vivo results indicate that Nedd4 family E3 
ligases, Nedd4-1 and Nedd4-2, play an evolutionarily conserved role in the 
regulation of axonal morphogenesis. 
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Figure 3-4. Nedd4-1 and Nedd4-2 Regulate Axon Growth in Mouse 
Cortical Neurons in vivo 
(A) Nedd4-1f/f;Nedd4-2f/f embryos were co-transfected with pFUGW (EGFP) 
and pCX-myrVenus (left), or pFUGWiCre (EGFP + Cre) and pCX-myrVenus 
(right) expression vectors using in utero electroporation. Scale bars, 500 µm. 
(B) High-magnification images of regions in red boxes in (A). Immunostaining 
for Cux1 was used to label layer II-IV neurons. Scale bars, 200 µm. (C) 
Quantification of the signal intensity from the cortical surface (cortical level 1) 
to the bottom of the white matter (WM) (cortical level 0) for axon projections 
at the contralateral side [see (A) and (B)]. The maximum signal in the white 
matter was set to 100% intensity. N1/2f/f, N=19 from 8 animals; NEX-N1/2f/f, 
N=11 from 5 animals. (D) Significant reduction in maximum intensity of 
axonal projections of Nedd4-1;Nedd4-2 double KO neurons in the upper 
layer and lower layer of the cortex [see (A-C)]. Upper layer (cortical level 0.7-
1): N1/2f/f, 269.8±27.72%; N1/2f/f+Cre, 161.7%±14.20%; **p=0.0019, 
unpaired t test with Welch's correction. Lower layer (cortical level 0.25-0.69): 
N1/2f/f, 222.9%±20.81%; N1/2f/f+Cre, 149.1%±8.64%; **p=0.0033, unpaired t 
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test with Welch's correction. Data are expressed as mean±SEM. N1/2f/f, 
Nedd4-1f/f;Nedd4-2f/f. NEX-N1/2f/f, NEX-Cre;Nedd4-1f/f;Nedd4-2f/f. 
3.1.2 PTEN is not Targeted by Nedd4-1 or Nedd4-2 for Proteosomal 
Degradation 
Given that PTEN was reported to be targeted by Nedd4-1 or Nedd4-2 
for proteasomal degradation in various tissues and organisms (Wang et al., 
2007; Drinjakovic et al., 2010; Yim et al., 2009; Christie et al., 2012), I next 
examined if PTEN is a substrate of Nedd4 family E3 ligases in the process of 
axon growth regulation. I studied the levels of PTEN by Western blotting of 
lysates prepared from developing neurons using an antibody to endogenous 
PTEN (see Figure 3-8A for the antibody specificity). Cre was expressed in 
Nedd4-1f/f;Nedd4-2f/f cultured hippocampal neurons using lentiviral infection 
in order to eliminate Nedd4-1 and Nedd4-2 from all cell types in the culture 
dish, including a small fraction of glial cells. Despite the fact that mammalian 
Nedd4-1 and Nedd4-2 are important for axon growth (Figures 3-3 and 3-4), I 
did not detect any concomitant upregulation of PTEN in cultured neurons at 
DIV8 upon deletion of Nedd4-1/Nedd4-2 (Figures 3-5 A and B, left panels). 
Rather, the PTEN protein levels were significantly reduced in Nedd4-
1;Nedd4-2 KO neurons at DIV15 (Figures 3-5 A and B, right panels), strongly 
arguing against that PTEN is targeted by Nedd4-1 or Nedd4-2 for 
proteosomal degradation. Overexpression of exogenous Cre does not affect 
Nedd4-1 and PTEN levels in wild-type neurons (Figures 3-5 C and D), 
indicating that the results I found in Figures 3-5 A and B are specific 
outcomes of Nedd4-1 and Nedd4-2 deletion in neurons. Similar results that 
no upregulation of the PTEN level upon deletion of Nedd4-1 and Nedd4-2 
were also obtained from P7 (Figures 3-5 E and F) and 5-week-old (Figures 3-
5 G and H) NEX-N1/2f/f brains, where Nedd4-1 and Nedd4-2 were deleted in 
postmitotic glutamatergic neurons. Taken together, these in vitro and in vivo 
data indicate that Nedd4-1 and Nedd4-2 are dispensable for proteasomal 
degradation of PTEN in developing mammalian neurons.  
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Figure 3-5. Normal Expression of PTEN in Neurons upon Deletion of 
Nedd4-1 and Nedd4-2 in vitro and in vivo  
(A) Representative Western blotting results showing that upon Nedd4-1 and 
Nedd4-2 deletion in cultured neurons, PTEN levels were unaltered at DIV8 
and downregulated at DIV15. Primary hippocampal neurons were prepared 
from Nedd4-1f/f;Nedd4-2f/f mice and Cre was expressed using lentiviral 
infection. (B) Quantification of PTEN levels by Western blotting [see (A)]. 
Signals for PTEN were normalized to signals for actin. *p=0.0471, N=3 per 
condition, unpaired t test. (C) Representative Western blotting results 
showing no difference in PTEN and Nedd4-1 levels when Cre was expressed 
in wild type hippocampal neurons using lentiviral infection, indicating that 
overexpression of exogenous Cre does not affect Nedd4-1 and PTEN levels 
in neurons. Neurons were harvested on DIV8 and DIV15. (D) Quantification 
results of Western blotting [see (B)] for PTEN and Nedd4-1 levels at DIV8 
(left) and at DIV 15 (right). No statistical differences were observed between 
groups. N=3 per group. Data are expressed as mean±SEM. (E and G) 
Representative Western blotting results showing levels of PTEN, AKT, 
phospho-AKT (p-AKT, Ser473), and GSK3β in brain lysates prepared from 
P7 mice (E) and 5-week-old mice (G) with the indicated genotypes. (F and H) 
Quantification of Western blotting results in (E) [see (F)] and (G) [see (H)]. 
Signals from the candidate proteins were normalized to the loading control. 
Phospho-AKT levels were normalized to total AKT levels and showed a slight 
downregulation in P7 but not 5-week-old NEX-Cre;Nedd4-1f/f;Nedd4-2f/f 
brains. PTEN, AKT, and GSK3β showed no difference in both P7 and 5-
week-old NEX-Cre;Nedd4-1f/f;Nedd4-2f/f brains as compared to controls. The 
residual expression of Nedd4-1 and Nedd4-2 in NEX-Cre;Nedd4-1f/f;Nedd4-
2f/f brains is likely from glial cells and inhibitory neurons. Given that PTEN 
levels and phosphatase activity were not affected (Figures 3-6 C and D), the 
decreased phospho-AKT (Ser473) levels in the P7 NEX-Cre;Nedd4-
1f/f;Nedd4-2f/f brain are likely due to misregulation of other substrates of 
Nedd4 family E3 ligases [e.g. growth factor receptors or phosphatases for 
phospho-AKT (Ser473)]. **p=0.002; ***p<0.001, unpaired t test. N=5 per 
group. Data are expressed as mean±SEM. 
3.1.3 PTEN Neither Poly- Nor Mono-ubiquitinated by Nedd4-1/Nedd4-2 
in Developing Mammalian Neurons 
A recent report indicated that Nedd4-1 conjugates K63-linked 
polyubiquitin chains to PTEN and thereby inhibits the phosphatase activity of 
PTEN without affecting its stability (Guo et al., 2012). To further confirm that 
PTEN is not polyubiquitinated by Nedd4-1 or Nedd4-2 in developing neurons, 
endogenous PTEN was immunoprecipitated from lysates of cortices 
prepared from P7 control and NEX-N1/2f/f mice. The ubiquitination level of 
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PTEN was then detected by Western blotting using anti-ubiquitin antibodies. 
In order to avoid ubiquitination signals from co-immunoprecipitated PTEN-
binding proteins, I performed immunoprecipitation of proteins under 
denaturing conditions. No reduction in the PTEN polyubiquitination levels 
was observed in NEX-N1/2f/f brains (Figures 3-6 A and B), further supporting 
the notion that PTEN is not polyubiquitinated by Nedd4-1 or Nedd4-2 in 
developing neurons. Next, I assessed the phosphatase activity of 
immunoprecipitated PTEN using an in vitro phosphatase assay. I titrated 
different amounts of the anti-PTEN antibody for immunoprecipitation (Figure 
3-6C), and measured the activity of PTEN immunoprecipitated from control 
or NEX-N1/2f/f mouse brains at the non-plateau phase of the assay where the 
readout of PTEN activity in the immunoprecipitates was not saturated. I 
found that the phosphatase activity of PTEN was unaltered in NEX-N1/2f/f 
brains (Figure 3-6D).  
Monoubiquitination by Nedd4-1 was reported to cause nuclear import of 
PTEN in mouse embryonic fibroblasts (Trotman et al., 2007). In view of this, I 
studied the subcellular distribution of PTEN in control and NEX-N1/2f/f 
neurons to examine if Nedd4-1 or Nedd4-2 regulates the 
compartmentalization of PTEN. I performed immunostaining of PTEN on 
cultured neurons at DIV7 using a specific antibody to PTEN (Figure 3-7A). In 
mouse hippocampal neurons, PTEN immunoreactivity was mostly confined 
to the cell body and proximal neurites, and very weak in axonal growth cones 
for both control and NEX-N1/2f/f neurons (Figures 3-7 B and C). The latter 
finding is strikingly different from data obtained in Xenopus laevis retinal 
ganglion cells (Drinjakovic et al., 2010). Importantly, PTEN was not 
noticeably enriched in nuclei, and the ratio of nuclear vs. total cellular PTEN 
was not altered in NEX-N1/2f/f neurons (Figures 3-7 D and E), indicating that 
the subcellular localization of PTEN in developing murine neurons is not 
regulated by Nedd4-1- or Nedd4-2-mediated monoubiquitination. Taken all 
together, these data indicate that Nedd4 family E3 ligases do not ubiquitinate 
PTEN, control PTEN localization, or affect the phosphatase activity of PTEN 
in developing mammalian neurons. 
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Figure 3-6. Normal Ubiquitination and Phosphatase Activity of 
Endogenous PTEN in Neurons upon Deletion of Nedd4-1 and Nedd4-2 
(A) No reduction of PTEN polyubiquitination levels in NEX-N1/2f/f mouse 
brains. (B) Quantification of PTEN polyubiquitination levels [see (A)]. The 
smear pattern (over 60 kD) was quantified and normalized to signals of 
immunoprecipitated PTEN. N=3 per genotype, unpaired t test. (C) 
Endogenous PTEN was immunoprecipitated from P7 mouse brain lysates 
with the indicated amount of anti-PTEN antibodies, and subjected to the 
PTEN phosphatase activity assay. Signals from the 'no PTEN' negative 
control were subtracted from all groups. Note that the readout of the assay 
was dependent on the PTEN amount. (D) Endogenous PTEN was 
immunoprecipitated with 14 ng of the anti-PTEN antibody [see (C)]. Normal 
PTEN phosphatase activity in P7 NEX-N1/2f/f brains as compared to N1/2f/f 
brains. Levels of immunoprecipitated PTEN (top blot) and genotypes of 
animals (middle and bottom blots) were confirmed by Western blotting. 
p=0.6859, N=3 per genotype, unpaired t test. Data are expressed as 
mean±SEM. N1/2f/f, Nedd4-1f/f;Nedd4-2f/f. NEX-N1/2f/f, NEX-Cre;Nedd4-
1f/f;Nedd4-2f/f. IB, immunoblotting. IP, immunoprecipitation. 
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Figure 3-7. Normal Localization of PTEN upon Deletion of Nedd4-1 and 
Nedd4-2  
(A) Specificity of the anti-PTEN antibody (clone D4.3; Cell Signaling) in 
immunostaining. Scale bars, 50 µm. (B and C) Overview of the subcellular 
localization of PTEN in hippocampal neurons prepared from Nedd4-
1f/f;Nedd4-2f/f mice (B), and NEX-Cre;Nedd4-1f/f;Nedd4-2f/f mice (C). Neurons 
were transfected with an EGFP expression vector at DIV1, fixed at DIV7, and 
immunostained for endogenous PTEN. High-magnification images of regions 
in white boxes are shown in the lower left panels. The soma and the axonal 
growth cone of the EGFP-expressing neuron are indicated by arrowheads 
and arrows, respectively. Note that PTEN signals at the axonal growth cone 
were very weak as compared to those in the soma and proximal neurites. 
Scale bars, 50 µm for low-magnification images, and 10 µm for high-
magnification images. (D) Representative images for control (Nedd4-
1f/f;Nedd4-2f/f) and Nedd4-1;Nedd4-2 double KO neurons (NEX-Cre;Nedd4-
1f/f;Nedd4-2f/f) immunostained for endogenous PTEN. Scale bars, 50 µm. (E) 
Quantification demonstrated no significant difference between the two groups 
[(see (D)] in the ratio of nuclear PTEN vs. total PTEN in the soma. p=0.991, 
unpaired t test with Welch's correction. Nedd4-1f/f;Nedd4-2f/f, N=83; NEX-
Cre;Nedd4-1f/f;Nedd4-2f/f, N=78. Data are expressed as mean±SEM. 
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3.1.4 PTEN Acts as a Negative Regulator of Nedd4-1 Expression at 
the Translational Level 
Although I excluded the possibility that PTEN acts as a downstream 
target of Nedd4-1/Nedd4-2 in the regulation of axon growth, several lines of 
evidence indicate an inverse correlation between the expression levels of 
Nedd4-1 and PTEN (Ahn et al., 2008; Amodio et al., 2010; Chung et al., 
2011; Kwak et al., 2010; Wang et al., 2007). These findings are compatible 
with the notion that PTEN may act as an upstream negative regulator of 
Nedd4-1 or Nedd4-2 expression. However, others reported a positive 
correlation between Nedd4-1 and PTEN expression (Yang et al., 2008b). To 
study if and how PTEN regulates the levels of Nedd4 family E3 ligases in 
developing neurons, I examined expression levels of Nedd4 family E3 
ligases in control and PTEN KO neurons. Of note, Nedd4-1 protein levels 
were significantly upregulated in the absence of PTEN while Nedd4-2 levels 
were unaltered, indicating that PTEN acts as an upstream negative regulator 
of Nedd4-1 expression in developing neurons (Figure 3-8A, left two lanes 
and Figure 3-8B). 
Given that PTEN is the prime negative regulator of PI3K-regulated 
intracellular signaling, I further investigated the possible involvement of 
signaling molecules of the PI3K/PTEN cascade in the regulation of Nedd4-1 
expression. Among those downstream molecules, I focused on mTORC1 
(serine/threonine protein kinase mammalian target of rapamycin complex 1), 
because it was reported to control dendrite growth (Jaworski et al., 2005). To 
test if mTORC1 is involved in the upregulation of Nedd4-1 expression upon 
PTEN deletion, I treated control and PTEN KO neurons with rapamycin, an 
inhibitor for mTORC1. Strikingly, the upregulation of Nedd4-1 expression in 
PTEN KO neurons was reverted by rapamycin treatment (20 nM for 24 h; 
Figure 3-8A, right two lanes and Figure 3-8B), indicating that the mTORC1 
activity is required for the PTEN-dependent regulation of Nedd4-1 
expression. Importantly, PTEN deletion did not affect Nedd4-1 mRNA 
expression while neurofilament H (NFH) mRNA, which was used as a 
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positive control, showed a significant upregulation upon PTEN loss (Figure 3-
8C). These results indicate that the PTEN-mTORC1 pathway functions 
upstream of Nedd4-1 to negatively regulate Nedd4-1 protein expression at 
the posttranscriptional level.  
I further investigated whether PTEN regulates Nedd4-1 mRNA 
translation or affects Nedd4-1 protein stability. In collaboration with Rossella 
Luca and Dr. Claudia Bagni (Leuven, Belgium), actively translating 
polysomes and silent mRNPs were isolated from cultured control and PTEN 
KO neurons using a continuous sucrose gradient. We found that Nedd4-1 
mRNA was more strongly associated with the polysomal fraction in PTEN KO 
neurons, as compared to control cells. Similar findings were obtained for 
Rpl13a mRNA, as shown previously (Thoreen et al., 2012), whereas the 
polysomal association of Nedd4-2 and GAPDH mRNAs was not changed in 
PTEN KO neurons (Figures 3-8 D and E). Because Nedd4-1 protein stability 
is not changed in PTEN KO neurons (Figure 3-8F), increased Nedd4-1 
mRNA translation is the likely cause for the observed increase in Nedd4-1 
protein levels (Figures 3-8 A and B). These results indicate that the PTEN-
mTORC1 pathway functions upstream of Nedd4-1 to negatively regulate 
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Figure 3-8. PTEN Negatively Regulates Nedd4-1 Expression at the 
Translational Level 
(A) Representative Western blotting results showing that upon deletion of 
PTEN, Nedd4-1 but not Nedd4-2 protein levels were upregulated (left two 
lanes) at DIV8. This upregulation was abolished by rapamycin treatment 
(right two lanes). Primary hippocampal neurons were prepared from PTENf/f 
mice and Cre was expressed using lentiviral infection. Reduction in phospho-
S6 (p-S6) levels was used as a positive control for rapamycin treatment. (B) 
Quantification of Western blotting results (see A). ***p<0.001, one-way 
ANOVA and Bonferroni's post hoc test, N=5 per condition. (C) Real-time 
quantitative PCR results showing that the Nedd4-1 mRNA level in mouse 
hippocampal neurons is not altered in the absence of PTEN. Neurofilament H 
(NFH) mRNA was used as a positive control for PTEN deletion. ***p<0.0001 
unpaired t test, N=4 per condition. (D) Representative polysome-messenger 
ribonucleoprotein (mRNPs) distribution on a sucrose gradient for cultured 
control and PTEN KO neurons. Fractions 1-7 correspond to polysome-
associated (translating) mRNAs. (E) Quantification of the relative 
translational efficiency of Nedd4-1, Rpl13a, Nedd4-2, and GAPDH mRNAs 
reported as the ratio of polysome-associated mRNAs over total mRNAs. 
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**p=0.004; *p=0.018 unparied t test, N=3. Rpl13a was used as a positive 
control (Thoreen et al., 2012) while GAPDH was a negative control. (F) 
Neurons (DIV8) were incubated with cycloheximide (CHX, 50 µg/ml) for 
different duration as indicated, and the Nedd4-1 level was assessed by 
Western blotting. The remaining Nedd4-1 level over time showed no 
difference between the two groups, indicating that the stability of Nedd4-1 
protein is not affected in PTEN KO neurons. Data are expressed as 
mean±SEM. 
3.1.5 Nedd4-1 is a Major Target of mTORC1 Signaling in Neurite 
Development 
To investigate the physiological importance of PTEN-regulated Nedd4-1 
expression in developing neurons, I studied the impact of genetic elimination 
of Nedd4-1 on neurite development in the PTEN KO background in cultured 
hippocampal neurons (Figures 3-9 A-E). Consistent with a previous report 
(Kwon et al., 2006), PTEN KO led to hypertrophy of neurites (Figures 3-9 A 
and B). This phenotypic change is opposite to the one seen upon Nedd4-1 
KO. Strikingly, additional KO of Nedd4-1 in PTEN KO neurons partially 
rescued the neurite hypertrophy phenotype (Figures 3-9 B-E), indicating that 
Nedd4-1 is a prominent regulator of neurite growth downstream of PTEN-
dependent signaling pathways. 
To study whether mTORC1 is involved in the PTEN- and Nedd4-1-
dependent regulation of neurite growth, I applied rapamycin to cultured 
control (Nedd4-1f/f) and Nedd4-1 conditional KO (NEX-Cre;Nedd4-1f/f; NEX-
N1f/f) neurons and quantified the neurite complexity (Figures 3-9 F-K). 
Consistent with previous findings (Jaworski et al., 2005), rapamycin 
treatment reduced the complexity of neurites in control neurons (Figures 3-9 
G, J, and K). In NEX-N1f/f neurons, however, the effect of rapamycin was not 
significant (Figures 3-9 H-K), indicating that mTORC1 functions upstream of 
Nedd4-1 and plays a role in the regulation of Nedd4-1 expression to promote 
neurite growth. These results, together with my biochemical data (Figures 3-
8), indicate that Nedd4-1 is a major downstream effector of the PI3K/PTEN-
mTORC1 pathway in the regulation of neurite development. 
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Figure 3-9. Nedd4-1 Has a Prominent Role in Neurite Morphogenesis 
and is Dependent upon mTORC1 Activity 
(A-C) Representative images of a control neuron (A), a PTEN KO neuron (B), 
and a PTEN;Nedd4-1 double KO neuron (C). Scale bars, 50 µm. (D) Sholl 
analyses for the three groups in (A-C). Note that KO of Nedd4-1 partially 
rescues the hypertrophy of neurite structure seen in PTEN KO neurons. (E) 
Statistical analysis of the total number of crossing neurites obtained in the 
Sholl analysis shown in (D). Data were analyzed by one-way ANOVA and 
Tukey's post hoc test (N>60 neurons per group). N.S., not significant. (F-I) 
Representative images of a control neuron treated with DMSO (F), a control 
neuron treated with rapamycin (G), a Nedd4-1 KO neuron treated with 
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DMSO (H), and a Nedd4-1 KO neuron treated with rapamycin (I). Scale bars, 
50 µm. (J) Sholl analyses for the four groups in (F-I). Note that rapamycin 
treatment had a milder effect on the dendritic structure in Nedd4-1 KO 
neurons. (K) Statistical analysis of the total number of crossing neurites 
obtained in the Sholl analysis shown in (J). Data were analyzed by one-way 
ANOVA and Tukey's post hoc test (N>60 neurons per group). Data are 
expressed as mean±SEM. N1f/f, Nedd4-1f/f. NEX-N1f/f, NEX-Cre;Nedd4-1f/f. 
3.1.6 Pathways Operating Parallel to the PI3K/PTEN-mTORC1-Nedd4-
1 Signaling Regulates Neurite Growth and Polarity Formation 
To explore the reason as to why there was only a partial rescue of the 
aberrantly enhanced neurite growth in PTEN KO neurons by additional KO of 
Nedd4-1 (Figures 3-9 A-E), I first applied rapamycin to control and PTEN KO 
neurons. Importantly, rapamycin treatment, like additional KO of Nedd4-1, 
did not completely rescue the neurite hypertrophy phenotype of PTEN KO 
neurons (Figures 3-10 A-F). This 'rapamycin insensitive fraction' of enhanced 
neurite growth in PTEN KO neurons may be contributed by pathways that 
operate in parallel to the PTEN/PI3K-mTORC1 pathway, e.g. the 
PTEN/PI3K-GSK3β pathway, and are thus not affected by rapamycin 
treatment or by additional KO of Nedd4-1. Accordingly, it has been reported 
that GSK3β plays a role in the regulation of dendrite growth (Rui et al., 2013). 
Secondly, in a subset of experiments shown in Figure 3-10, I performed the 
rapamycin treatment on PTEN;Nedd4-1 double KO neurons. I found that 
rapamycin had hardly any effect on neurite growth in PTEN;Nedd4-1 double 
KO neurons, further supporting the notion that Nedd4-1 operates 
downstream of mTORC1 (Figures 3-10 G-I, see also Figures 3-9 F-K). Of 
note, while PTEN KO neurons tend to project more than one axon because 
of deregulation of another signaling molecule downstream of PTEN, GSK3β 
(Jiang et al., 2005), this gain-of-function phenotype in axon acquisition was 
independent of Nedd4-1/Nedd4-2 deletion (Figure 3-11). Taken together, 
these results of analyzing the neurite complexity and polarity formation of 
PTEN KO neurons indicate that additional pathways operating parallel to 
PI3K/PTEN-mTORC1-Nedd4-1 contributes to the neurite growth regulation, 
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and these pathways are also responsible for the PTEN-regulated neuronal 
polarity formation. 
Figure 3-10. Enhanced mTORC1 Activity Partially Accounts for the 
Hypertrophy of Neurites in PTEN KO Neurons  
(A-D) Representative images of a control neuron treated with DMSO (A), a 
control neuron treated with rapamycin (B), a PTEN KO neuron treated with 
DMSO (C), and a PTEN KO neuron treated with rapamycin (D). Cultured 
hippocampal neurons were prepared from PTENf/f mice and transfected with 
an EGFP and Cre expressing vector (PTEN KO). Control neurons were 
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prepared from littermates and transfected with the EGFP-only expressing 
vector. Scale bars, 50 µm. (E) Sholl analyses for the four groups in (A-D). 
Note the difference between 'PTEN KO + rapa' and 'control + rapa' groups, 
indicating that pathways independent of mTORC1 activity also contribute to 
the enhanced neurite growth in PTEN KO neurons. (F) Statistical analysis of 
the total number of crossing neurites obtained in the Sholl analysis shown in 
(E). Data were analyzed by one-way ANOVA and Tukey's post hoc test 
(N>49 neurons per group). (G and H) Representative images of a 
PTEN;Nedd4-1 double KO (DKO) neuron treated with DMSO (G), or with 
rapamycin (H). Scale bars, 50 µm. Cultured hippocampal neurons were 
prepared from littermates with the genotype PTENf/f;Nedd4-1f/f, and 
transfected with an EGFP and Cre expressing vector. (I) Sholl analyses for 
the two groups in (G) and (H). Note that rapamycin had hardly any effect on 
dendrite growth in PTEN;Nedd4-1 double KO neurons. (J) Statistical analysis 
of the total number of crossing neurites obtained in the Sholl analysis shown 
in (I). Data obtained in (G-J) are from a subset of experiments shown in (A-F). 
p=0.9333 unpaired t test, PTEN;Nedd4-1 DKO+DMSO, N=49; PTEN;Nedd4-
1 DKO+Rapa, N=60. Data are expressed as mean±SEM. 
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Figure 3-11. Nedd4-1 and Nedd4-2 are Dispensable for PTEN-Mediated 
Establishment of Neuronal Polarity  
(A) Representative images of control (top panels), Nedd4-1;Nedd4-2 double 
KO (second panels from the top), and Nedd4-1;Nedd4-2;PTEN triple KO 
neurons (bottom panels). Primary hippocampal neurons prepared from the 
indicated genotypes were transfected with an EGFP expressing vector or an 
EGFP and Cre co-expressing vector at DIV1 and fixed at DIV7. Staining for 
AnkyrinG (AnkG) was used to label axon initial segments. Scale bars, 50 µm. 
(B) Statistical analysis of the number of axons for the three groups in (A). 
The percentage of neurons projecting multiple axons was increased in 
Nedd4-1;Nedd4-2;PTEN triple KO neurons as compared to Nedd4-1;Nedd4-
2 double KO neurons (***p<0.0001, chi-square test) and control neurons 
(***p=0.0005, chi-square test). Nedd4-1;Nedd4-2 double KO neurons, on the 
other hand, showed no significant difference as compared to control neurons. 
N>120 neurons per group. (C) Representative images of control (top panels), 
and PTEN KO neurons (bottom panels). Scale bars, 50 µm. (D) Statistical 
	   Results	  
70	  
	  
analysis of the number of axons for the two groups in (C). A significantly 
increased percentage of PTEN KO neurons projected multiple axons as 
compared to control neurons. *p=0.0394, chi-square test. Control, N=123; 
PTEN KO, N=115. Data are expressed as mean±SEM. 
3.1.7 Working Model 
In the present study, I demonstrate that the Nedd4 family E3 ubiquitin 
ligases, Nedd4-1 and Nedd4-2, promote axon growth in mammalian central 
nervous system (CNS) neurons independently of PTEN acting as a 
downstream substrate. Instead, PTEN acts upstream of Nedd4-1 to 
negatively regulate Nedd4-1 expression at the translational level via 
mTORC1 to control neurite growth (Figure 3-12) 
Figure 3-12. Model of the Regulation of Nedd4-1 by the PI3K/PTEN-
mTORC1 Signaling Pathway during Neurite Growth 
PI3K catalyzes the phosphorylation of PtdInsP2 to generate PtdInsP3 (e.g. in 
response to growth factor or hormone stimulation). PTEN converts PtdInsP3 
back to PtdInP2 and thus antagonizes the effect of PI3K. Elevated PtdInsP3 
levels lead to the phosphorylation of AKT, which further phosphorylates 
GSK3β and mTORC1. The phosphorylation of GSK3β promotes axon 
acquisition in neurons (Jiang et al., 2005). On the other hand, AKT 
dependent activation of mTORC1 stimulates downstream pathways that 
include the protein translation machinery. Nedd4-1 is important for neurite 
outgrowth but dispensable for axon acquisition, and its mRNA is a prominent 
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target of regulation by mTORC1 at the translational level. Nedd4-1 is not 
responsible for PTEN ubiquitination or regulation in developing mammalian 
neurons. 
3.2 Roles of the E3 Ligases WWP1 and WWP2 during 
Mammalian Brain Development 
3.2.1 Identification of Binding Partners of WWP1 
To study the roles of WWP1 in brain development, I first affinity-purified 
WWP1 binding proteins from P7 mouse brains. Recombinant GST-tagged 
full-length WWP1 WT (GST-WWP1 WT) was purified from E. coli and 
immobilized on glutathione sepharose beads, followed by incubation with an 
extract of brain synaptosomes prepared from P7 WT mice. Proteins bound to 
the beads were subsequently eluted with buffer containing 1 M NaCl, 
followed by 40 mM glutathione (Figure 3-13). Using mass spectrometric 
methods in collaboration with Dr. Olaf Jahn (Proteomics Group, MPI-EM, 
Göttingen), we identified several proteins that were specifically enriched in 
the eluate from a GST-WWP1 column loaded with brain lysates (Table 3-1). 
Of note, one of the candidates was shown on Coomassie-stained gels as a 
clearly distinct band and was resistant to 1 M NaCl elution (Figure 3-13, 
number 1), indicating a strong affinity between this candidate protein and 
WWP1. The subsequent mass spectrometric analyses identified this protein 
with high confidence as 'probable ubiquitin carboxyl-terminal hydrolase 
(Usp9x)'. The interaction between Usp9x and WWP1/WWP2 was further 
studied by immobilizing recombinant GST-WWP1 WT and GST-WWP2 WT 
on columns, followed by loading the columns with lysates prepared from 
HEK293FT cells overexpressing V5-Usp9x. The interaction between V5-
Usp9x and WWP1/WWP2 were confirmed by Western blotting using an 
antibody to V5, which detected specific signals of V5-Usp9x for the GST-
WWP1 and GST-WWP2 column eluates but not for the negative control 
(Figure 3-14, top blots). I therefore focused on studying a possible functional 
interaction between Usp9x and WWP1/WWP2. 
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Figure 3-13. Affinity Purification of WWP1 Binding Proteins from P7 
Mouse Brains 
GST-WWP1 binding proteins were affinity-purified from an extract of brain 
synaptosomes (P2) prepared from P7 WT mice. A GST column loaded with 
extract of brain synaptosomes and a GST-WWP1 column only loaded with 
buffer were used as negative controls. Proteins were separated on a pre-cast 
NuPAGE 4%-12% Bis-Tris gradient gel (Invitrogen) using the MOPS-based 
buffer system, and visualized by Coomassie staining. Several individual 
bands specifically enriched by the GST-WWP1 column loaded with extract of 
brain synaptosomes (indicated by numbers) were excised for further analysis 
using mass spectrometry. Note that the band number 1 was shown as a 
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Table 3-1. List of Brain Specific WWP1 Binding Proteins Identified by 
Mass Spectrometry  
Number# Protein Name Accession Number 
1 Probable ubiquitin carboxyl-terminal hydrolase FAF-X (Usp9x) gi|115511018 
2 Tubulin beta-2C chain gi|5174735 
3 WW domain-binding protein 2 gi|1110559 
4 Cleavage and polyadenylation specificity factor subunit 6 gi|26338454 
5 Heat shock protein 70 cognate gi|309319 
#Numbers correspond to bands indicated in Figure 3-13 
 
Usp9x was reported as the deubiquitinase that removes polyubiquitin 
chains from the AMPK-related kinase Nuak1 and thereby activates the 
kinase activity of Nuak1 (Al-Hakim et al., 2008). During mammalian axon 
morphogenesis, Nuak1 is phosphorylated and activated by LKB1 to promote 
axonal branching of cortical neurons (Courchet et al., 2013). Thus, I 
investigated the possibility that WWP1 also targets Nuak1 and antagonizes 
the function of Usp9x by acting upon the same effector protein. To test this, I 
studied if Nuak1 and its closest homologue Nuak2 interact with WWP1 or 
WWP2. Lysates prepared from HEK293FT cells overexpressing Flag-Nuak1 
or HA-Nuak2 were loaded onto a GST-WWP1 or a GST-WWP2 column and 
the bound fractions were analyzed by Western blotting using antibodies to 
Flag and HA, respectively. I found specific interactions between both Nuak1 
and Nuak2 with WWP1/WWP2 (Figure 3-14, middle and bottom blots), 
indicating that similar to Usp9x, WWP1 and WWP2 may also play roles in 
regulating the functions of Nuak1 or Nuak2. 
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Figure 3-14. Interactions of Usp9x, Nuak1, and Nuak2 with WWP1 and 
WWP2 
Lysates prepared from HEK293FT cells overexpressing V5-Usp9x, Flag-
Nuak1, or HA-Nuak2 were loaded on GST, GST-WWP1 or GST-WWP2 
columns. Bound fractions were subjected to Western blotting using 
antibodies for V5, Flag, or HA, respectively. Note that there is specific 
binding of Usp9x, Nuak1, and Nuak2 to both WWP1 and WWP2. 
3.2.2 Proteomic Based Screening of Ubiquitination Substrates of 
WWP1 and WWP2 in Mouse Brains 
In addition to the identification of WWP1 and WWP2 binding proteins, 
which may potentially be ubiquitination substrates of WWP1 or WWP2, I also 
used a proteomics based screening service provided by Cell Signaling 
Technology (PTMscan) to directly screen for ubiquitination substrates in an 
unbiased manner. Briefly, brain lysates were prepared from control and Emx-
Cre;WWP1f/f;WWP2f/f mice and proteins were trypsinized. The resulting 
peptides with di-glycine remnants from ubiquitin left on the lysine residues 
(K-ε-GG) were immunopurified with an antibody specific to K-ε-GG (Cell 
Signaling). The K-ε-GG enriched proteomes were then identified and 
quantified using mass spectrometry (see also Figure 1-3). Several proteins 
showing a robust decreased ubiquitination level in Emx-Cre;WWP1f/f;WWP2f/f 
brains as compared to control brains appear to be potential substrates of 
WWP1 or WWP2 (Table 3-2). I further validated the proteomics results with 
an in vitro ubiquitination assay using recombinant E1, E2s (both from Boston 
Biochem), E3s (purified from E. coli) and the candidate proteins as 
substrates. Candidate proteins were either overexpressed with an N-terminal 
Myc-tag in HEK293FT cells and immunopurified using anti-Myc agarose 
beads, or overexpressed with an N-terminal GST-tag in E. coli and purified 
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with glutathione sepharose beads, followed by removing the GST-tag with 
thrombin or prescission protease. Of the candidate proteins I tested, Tuba4A, 
UBE1, Pkar1b, and Cdk5 were ubiquitinated by the WWP ligases in vitro, but 
MEKK6 was not (Figure 3-15). These proteomics and in vitro ubiquitination 
results indicate that Tuba4A, UBE1, Pkar1b, and Cdk5 are prominent 
substrates of WWP1/WWP2 in the developing mammalian brain.  
 
Table 3-2. List of Potential Substrate Proteins of WWP1 and WWP2 
























-2.5 6714.891 Uba1 UBE1 Q02053 
-2.2 893.872 Prkar1b Pkar1b P12849 
Cdk5, cyclin-dependent kinase 5; MEKK6, mitogen-activated protein kinase 
kinase kinase 6; Tuba3C, tubulin alpha-3C; Tuba1B, tubulin alpha-1B; 
Tuba4A, tubulin alpha-4A; UBE1, ubiquitin-activating enzyme 1; Pkar1b, 
cAMP-dependent protein kinase type I-beta regulatory subunit. 
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Figure 3-15. Validation of the Proteomic Screening Results 
Potential substrate proteins of WWP1/WWP2 identified in the proteomic 
screening (Table 3-2) were validated using an in vitro ubiquitination assay. 
The recombinant candidate proteins were either purified from HEK293FT 
cells (Tuba4A, UBE1, Pkar1b, and MEKK6) or E. coli (Cdk5). The results 
were analyzed by Western blotting using the indicated antibodies. Note that 
Tuba4A, UBE1, and Pkar1b were mono- and di-ubiquitinated by WWP1, and 
Cdk5 was poly-ubiquitinated by WWP1 and WWP2 in vitro. MEKK6 was not 
a substrate of WWP1 in vitro. The mono- and di-ubiquitinated forms of 
candidate proteins are indicated by arrowheads. 
3.2.3 Cdk5 is a Physiological Substrate of WWP1 and WWP2 
Numerous reports indicated that Cdk5 plays important roles in 
mammalian neural development (reviewed by Dhavan and Tsai, 2001; Su 
and Tsai, 2011). I therefore focused on studying if Cdk5 is a physiological 
substrate of WWP1 and WWP2. To test if Cdk5 is ubiquitinated by WWP1 
and WWP2 in vivo, I overexpressed Myc-Cdk5 together with WWP1 or 
WWP2 in HEK293FT cells. Myc-Cdk5 was then immunoprecipitated from the 
cell lysates under denaturing conditions using anti-Myc agarose beads 
(Sigma), and its ubiquitination level was studied by Western blotting to 
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ubiquitin. Of note, Cdk5 was ubiquitinated by WWP1 and WWP2 in vivo, 
since the higher molecular weight smear pattern detected in the anti-ubiquitin 
blot was increased in samples with co-expressed WWP1 or WWP2, as 
compared to the ligases only or the Myc-Cdk5 only negative controls (Figure 
3-16A). This increase in the higher molecular weight smear pattern was also 
apparent in the anti-Myc blot (Figure 3-16A). In addition, I investigated if the 
ubiquitination level of Cdk5 is reduced in WWP1;WWP2 KO neurons as 
compared to control neurons. Myc-Cdk5 was overexpressed in cultured 
control and WWP1;WWP2 KO hippocampal neurons using the lentivirus 
system, followed by an anti-Myc immunoprecipitation under denaturing 
conditions and Western blotting to ubiquitin. Strikingly, deletion of 
WWP1/WWP2 in neurons reduced the ubiquitination level of Cdk5 (Figure 3-
16B). Together, the data obtained in HEK293FT cells and neurons indicate 
that Cdk5 is a physiological ubiquitination substrate of WWP1/WWP2.  
Given that Cdk5 has a PY motif that was reported to be important for 
binding to the WW-domains of Nedd4 family ligases (reviewed by Rotin and 
Kumar, 2009), I further studied if Cdk5 directly interacts with WWP1 and 
WWP2 and if these interactions are dependent on the PY motif of Cdk5. For 
this purpose, I immobilized recombinant GST-Cdk5 WT and GST-Cdk5 PY 
motif mutant (Cdk5 P234A, Y236F) on columns and loaded the columns with 
recombinant full-length WWP1 WT or WWP2 WT purified form E. coli. The 
bound fractions were collected and analyzed by Western blotting using anti-
WWP1 or anti-WWP2 antibodies. Interestingly, both WWP1 and WWP2 
bound to Cdk5 WT but the affinities to the Cdk5 PY motif mutant were 
weaker, indicating that WWP1/WWP2 interact directly with Cdk5 and that 
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Figure 3-16. Cdk5 Interacts Directly with WWP1/WWP2 and is a 
Physiological Substrate of WWP1/WWP2 
(A) Cdk5 is ubiquitinated by WEMBO	  Molecular	  MedicineWP1/WWP2 in vivo. 
Myc-Cdk5 was overexpressed in HEK293FT cells together with WWP1 or 
WWP2, immunoprecipitated with anti-Myc agarose beads, and its 
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ubiquitination level was studied by Western blotting to ubiquitin. Note that the 
smear patterns shown in the anti-ubiquitin blot and the anti-Myc blot are 
increased when Myc-cdk5 was co-expressed with WWP1 or WWP2, as 
compared to the negative controls (first two lanes). Specific bands for 
overexpressed WWP2 are indicated by the arrow. (B) Reduced ubiquitination 
level of Cdk5 in WWP1;WWP2 DKO neurons. Cultured hippocampal neurons 
were prepared from WWP1f/f;WWP2f/f mice, and vectors expressing EGFP 
(Control) or EGFP and Cre (DKO) were expressed using lentiviral infection at 
DIV0. Myc-Cdk5 was overexpressed in control and WWP1;WWP2 KO 
neurons using lentiviral infection at DIV1. Neurons were harvested at DIV14. 
Myc-Cdk5 was immunoprecipitated with anti-Myc agarose beads and its 
ubiquitination level was studied by Western blotting to ubiquitin. (C) Cdk5 
directly binds to WWP1/WWP2 via the PY motif of Cdk5. 45 µg of 
recombinant GST-Cdk5 WT and GST-Cdk5 PY mutant (P234A, Y236F) was 
immobilized on glutathione sepharose beads, and incubated with 10 µg of 
recombinant full-length WWP1 or WWP2. The bound fractions were analyzed 
by Western blotting using anti-WWP1 and anti-WWP2 antibodies (first and 
third panels). Note that both WWP1 and WWP2 specifically bind to Cdk5 WT, 
but the affinities are weaker to the Cdk5 PY motif mutant. Similar amounts of 
immobilized GST and GST-fusion proteins were confirmed by the Memcode 
(Pierce) staining (second and fourth panels). IB, immunoblotting. IP, 
immunoprecipitation. Ub, ubiquitin. 
3.2.4 Regulation of Cdk5 by WWP1/WWP2 Mediated Ubiquitination 
Next, I investigated the possible roles of Cdk5 ubiquitination by WWP1 
and WWP2. I first studied whether the polyubiquitin chains conjugated on 
Cdk5 by the WWP ligases are K48-linked or K63-linked, given that K48-
linked polyubiquitination targets the substrate protein for proteosomal 
degradation, whereas K63-linked polyubiquitination plays roles in other 
regulatory processes (reviewed by Ikeda and Dikic, 2008). For this purpose, 
Myc-Cdk5 was overexpressed in HEK293FT cells together with WWP1 or 
WWP2, and either HA-ubiquitin WT, HA-ubiquitin K48R, or HA-ubiquitin 
K63R. Myc-Cdk5 was then immunoprecipitated under denaturing conditions 
with anti-Myc agarose beads, and its ubiquitination level was studied by 
Western blotting using an antibody to HA. Interestingly, both WWP1 and 
WWP2 mainly conjugated K63-linked polyubiquitin chains but not K48-linked 
polyubiquitin chains to Cdk5, as indicated by the fact that co-expression of 
the HA-ubiquitin K63R mutant reduced the polyubiquitination level of Cdk5, 
whereas co-expression of the HA-ubiquitin K48R had no effect on the Cdk5 
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ubiquitination level as compared to co-expression of the HA-ubiquitin WT 
(Figure 3-17 A and B). These results indicate that WWP1/WWP2 do not 
regulate the proteasomal degradation of Cdk5 by conjugating K48-linked 
polyubiquitin chains. Rather, WWP1/WWP2 may regulate the function or 
subcellular localization of Cdk5 by conjugating K63-linked polyubiquitin 
chains on Cdk5.  
Activation of the kinase activity of Cdk5 requires binding of Cdk5 with its 
activators, p35 or p39 (Ko et al., 2001; Tsai et al., 1994). To study if the 
binding of Cdk5 with p25, an N-terminally truncated form of p35, interferes 
with the ubiquitination of Cdk5 by WWP1/WWP2, I overexpressed Myc-Cdk5 
together with or without HA-p25 in HEK293FT cells. Myc-Cdk5 was then 
immunopurified using anti-Myc agarose beads and subjected to an in vitro 
ubiquitination assay. Strikingly, co-expression of HA-p25 reduced the 
ubiquitination efficiency of Myc-Cdk5 by WWP1 in vitro, indicating that 
binding with p25 hinders ubiquitination of Cdk5 by WWP1 (Figure 3-17C). 
This result is also compatible with the notion that Cdk5 ubiquitination by 
WWP ligases may hinder the binding of Cdk5 with its activators, and thereby 
interfere with the activation of Cdk5. Taken together, my current results 
indicate that ubiquitination of Cdk5 by WWP ligases may regulate the kinase 
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Figure 3-17 Regulation of Cdk5 by WWP Ligase-Mediated Ubiquitination 
(A and B) WWP1 and WWP2 mainly conjugate K63-linked polyubiquitin 
chains rather than K48-linked polyubiquitin chains to Cdk5. Myc-Cdk5 was 
overexpressed in HEK293FT cells together with WWP1 (A) or WWP2 (B), 
and either HA-ubiquitin WT, HA-ubiquitin K48R, or HA-ubiquitin K63R. Myc-
Cdk5 was then immunoprecipitated and its ubiquitination level was studied 
by Western blotting to ubiquitin. Note that for both WWP1 and WWP2, the 
smear patterns of polyubiquitination of Myc-Cdk5 were reduced if co-
expressed with HA-ubiquitin K63R. (C) Binding of Cdk5 with its activator p25 
reduces ubiquitination of Cdk5 by WWP1. Myc-Cdk5 was overexpressed in 
HEK293FT cells together with (left blot) or without (right blot) HA-p25, 
immunoprecipitated with anti-Myc agarose beads, and subjected to an in 
vitro ubiquitination assay using WWP1 as the E3 ligase. Note that the 
ubiquitination efficiency of Cdk5 by WWP1 is reduced when HA-p25 was co-
expressed. Shown results were obtained from the same set of experiments 
on the same blot. IB, immunoblotting. IP, immunoprecipitation. Ub, ubiquitin.




4.1 PTEN is Not a Relevant Substrate of Mammalian Nedd4 
Family E3 Ligases in the Regulation of Neurite 
Development 
Nedd4-1 is the first ubiquitin E3 ligase to be implicated in the mono- and 
polyubiquitination of PTEN (Wang et al., 2007). Based on this initial study, it 
was proposed that Nedd4-1 regulates the expression level, phosphatase 
activity, and nuclear import of PTEN in various cell types (Ahn et al., 2008; 
Christie et al., 2012; Chung et al., 2011; Guo et al., 2012; Kwak et al., 2010; 
Trotman et al., 2007; Yim et al., 2009). However, the issue of whether PTEN 
is ubiquitinated and regulated by Nedd4-1 is highly controversial, given that 
other groups reported that PTEN protein expression and subcellular 
distribution are not altered in Nedd4-1 KO or Nedd4-1 KD cells (Fouladkou et 
al., 2008; Cao et al., 2008; Yang et al., 2008a). Several other groups also 
identified alternative E3 ligases targeting PTEN, including XIAP, WWP2, and 
CHIP (Ahmed et al., 2012; Maddika et al., 2011; Van Themsche et al., 2009), 
suggesting the possibility that the regulation of PTEN by ubiquitination may 
be cell type specific or context dependent. 
In the postmitotic developing neurons, mouse Nedd4-1 promotes 
dendritic growth in hippocampal and cortical neurons by monoubiquitinating 
the small GTPase Rap2A (Kawabe et al., 2010), whereas xNedd4, which is 
more homologous to mammalian Nedd4-2, promotes axonal branching in 
Xenopus laevis retinal ganglion neurons by polyubiquitinating PTEN and 
target it for proteosomal degradation (Drinjakovic et al., 2010). The 
conclusions regarding the role of xNedd4 in Xenopus laevis retinal ganglion 
cells were mainly based on results showing that (i) axonal branching of 
retinal ganglion cells is inhibited upon overexpression of dominant negative 
xNedd4 or KD of xNedd4; (ii) PTEN levels are increased in axonal growth 
cones of dominant negative xNedd4 overexpressing or xNedd4 KD neurons; 
(iii) the impairment in axonal branching upon xNedd4 KD is rescued by 
	   Discussion	  
83	  
	  
simultaneous downregulation of endogenous PTEN; (iv) overexpression of a 
ubiquitin K48R mutant also impairs the axonal branching in retinal ganglion 
cells; and (v) application of a proteasome inhibitor blocks the Netrin-1-
induced PTEN degradation and growth cone collapse (Drinjakovic et al., 
2010). This study on the roles of xNedd4 in PTEN regulation has challenged 
the finding that PTEN expression levels were unaltered in Nedd4-1 KO 
mouse embryonic fibroblasts (Fouladkou et al., 2008). The latter paper, 
nevertheless, does not exclude the possibility that loss of Nedd4-1 is 
compensated by its closest mammalian homologue Nedd4-2. 
In the present study, I tackle this highly contentious issue of whether 
PTEN is ubiquitinated by Nedd4-1 or Nedd4-2 in mammalian CNS neurons 
by using the brain specific Nedd4-1 single, Nedd4-2 single, and Nedd4-
1;Nedd4-2 double conditional KO mouse lines, which are the cleanest tools 
available for this purpose. I found that Nedd4-2 has a similar function as 
Nedd4-1 in the regulation of neurite branching (Kawabe et al., 2010 and 
Figure 3-1), and that Nedd4-1/Nedd4-2 deletion causes defects in axonal 
morphogenesis of mouse hippocampal and cortical neurons in a manner 
similar to what has been observed in Xenopus laevis retinal ganglion cells 
(Figures 3-3 and 3-4). However, I found no concomitant misregulation of 
PTEN in Nedd4-1;Nedd4-2 double KO neurons. My data clearly show that 
alterations in PTEN levels, localization, or function cannot be involved in the 
regulation of axon growth by Nedd4 family E3 ligases (Figures 3-5, 3-6, and 
3-7). These data indicate that the results observed upon perturbation of 
endogenous xNedd4 functions by overexpressing the dominant negative 
xNedd4 or using a single sequence morpholino-based xNedd4 KD may not 
be sufficiently conclusive, as some off-target effects might occur. Particularly, 
the result of simultaneous KD of PTEN and xNedd4 rescue the impaired 
axonal branching phenotype upon xNedd4 KD does not offer a causal 
relationship between PTEN and xNedd4 (Drinjakovic et al., 2010). 
Correspondingly, I found that PTEN operates upstream to negatively regulate 
Nedd4-1 expression, which can also account for their observed results 
(Figure 3-8). In addition, the finding that PTEN is conjugated with K48-linked 
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polyubiquitin chains by xNedd4 is questionable, as multiple publications have 
indicated that Nedd4 superfamily E3 ligases mainly conjugate K63-linked 
polyubiquitin chains for non-proteolytic purposes (Kamadurai et al., 2013; 
Kim and Huibregtse, 2009). 
Although I found no evidence that PTEN is regulated by Nedd4-
1/Nedd4-2 during the development of mammalian CNS neurons, based on 
the current dataset I cannot exclude the possibilities that PTEN ubiquitination 
by Nedd4 family E3 ligases is only functionally relevant in specific neuron 
types such as Xenopus laevis retinal ganglion cells and mammalian 
peripheral neurons (Drinjakovic et al., 2010; Christie et al., 2012), or that 
ubiquitination of PTEN only occurs in specific contexts such as neuronal 
protection upon ischemic stress or zinc insult (Howitt et al., 2012; Kwak et al., 
2010). However, in the report showing that Nedd4-1/Nedd4-2 may be 
relevant for PTEN ubiquitination and nuclear import for neuronal protection 
upon ischemic stress, the conclusion was mainly based on the observation 
that PTEN localization is altered in Nedd4 family–interacting protein 1 (Ndfip1) 
KO mouse brains (Howitt et al., 2012). Ndfip1 is an adaptor protein for the 
Nedd4 superfamily E3 ligases, and may act as an activator for the Nedd4 
ligases by releasing them from the autoinhibitory conformation (Mund and 
Pelham, 2009). Nevertheless, no direct evidence was obtained that the 
activity of Nedd4-1 or Nedd4-2 is affected in Ndfip1 KO mouse brains (Howitt 
et al., 2012). Furthermore, subsequent studies on Ndfip1 KO mice by the 
same group also indicated that Ndfip1 is important for the export of PTEN to 
exosomes independently of Nedd4-1 or Nedd4-2 (Putz et al., 2012), and that 
KO of Ndfip1 in embryonic cultured neurons and developing brains results in 
increased complexity of neurites and elevated p-AKT (S473) levels 
(Hammond et al., 2013), which are opposite to the phenotypes seen in 
Nedd4-1;Nedd4-2 KO mice (Kawabe et al., 2010 and Figures 3-1, 3-3, 3-4, 
and 3-5 E and F). These results indicate that Ndfip1 may have a role in 
regulating PTEN independent of the Nedd4-1 or Nedd4-2 mediated PTEN 
ubiquitination. 
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4.2 PTEN Negatively Regulates Nedd4-1 Expression at the 
Translational Level 
4.2.1 Nedd4-1 is a Major Target of the PI3K/PTEN-mTORC1 Signaling 
in Neurite Development 
Beyond merely excluding a role of Nedd4 family E3 ligases in the 
regulation of PTEN levels, localization, or function in mammalian CNS 
neurons, my present work also provides evidence for a strikingly inverse 
scenario, according to which PTEN antagonizes the PI3K-mTORC1 pathway 
to limit Nedd4-1 mRNA translation and neurite growth. Importantly, my 
working model (Figure 3-12), in which PTEN acts as an upstream negative 
regulator of Nedd4-1, can also account for the inverse correlation between 
expression levels of PTEN and Nedd4-1 found in previous studies (Ahn et al., 
2008; Amodio et al., 2010; Kwak et al., 2010; Wang et al., 2007). However, 
these findings also raise the question as to why Nedd4-1 mRNA is 
preferentially targeted by the mTORC1 signaling. 
Activation of the PI3K-mTORC1 signaling promotes protein synthesis 
mainly by mediating the phosphorylation of eukaryotic initiation factor 4E 
binding protein 1 and 2 (4E-BP1 and 4E-BP2). Under basal conditions, 4E-
BPs bind to eukaryotic initiation factor 4E (elF4E) to prevent the formation of 
protein initiation complex and protein translation. Phosphorylation of 4E-BPs 
leads to decreased affinity of 4E-BPs to eIF4E, enabling eIF4E to be 
anchored to the 5'-cap structure of mRNAs and the formation of protein 
initiation complex to start protein synthesis (reviewed by Gingras et al., 
1999). PTEN suppresses this process by counteracting PI3K-mTORC1 
activation, and thereby negatively regulates the translation of Nedd4-1 
mRNA (Figure 3-7). Further data supporting this regulation include a 
published study employing ribosome profiling to examine the translational 
efficiency of specific mRNAs in the presence of an mTORC1 inhibitor, and 
showing that the translational efficiency of Nedd4-1 mRNA is reduced upon 
mTORC1 inhibition (Thoreen et al., 2012). Of note, the 5' untranslated region 
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(5'UTR) of Nedd4-1 mRNA (GenBank accession number: NM_010890) 
contains a pyrimidine-rich sequence stretch that is related to the 5' terminal 
oligopyrimidine (5'TOP) motif. This motif is important for anchoring elF4E to 
the 5'-cap structure of the mTORC1 target mRNAs to initiate protein 
synthesis upon phosphorylation of 4E-BPs. The pyrimidine-rich sequence in 
the 5'UTR of Nedd4-1 mRNA may therefore play a similar role as the 5'TOP 
motif in starting translation of Nedd4-1 mRNA in a mTORC1 activity-
dependent manner.  
In addition to the biochemical results showing that PTEN acts as an 
upstream regulator to negatively regulate Nedd4-1 translation (Figure 3-7), I 
also provide evidences indicating that Nedd4-1 is a major target of the 
PI3K/PTEN-mTORC1 signaling to regulate neurite development (Figures 3-9 
and 3-10). In view of other published results indicating an important role of 
protein synthesis in neurite growth (Jaworski et al., 2005; Kumar et al., 
2005), these data are compatible with the notion of Nedd4-1 mRNA as a 
major target of the local translational machinery in growing neurites. 
Importantly, accumulating evidences indicate the crucial roles of local protein 
synthesis in various aspects of normal neuronal development and function, 
such as axon guidance, dendritic spine formation, and synaptic plasticity 
(reviewed by Holt and Schuman, 2013; Jung et al., 2012; Sutton and 
Schuman, 2006). The notion that Nedd4-1 expression may be regulated by 
the neuronal local translational machinery, therefore, indicates that Nedd4-1 
may have important functions in other aspects during neuronal development 
in addition to the neurite growth regulation. 
4.2.2 Possible Roles of Nedd4-1 in Insulin-Like Growth Factor-1 (IGF-
1) Signaling 
Cortical neurons of the igf1 KO mouse show a decreased length and 
complexity of dendrites, indicating a role of IGF-1 in promoting dendritic 
development (Cheng et al., 2003). On the other hand, multiple publications 
have reported a role of Nedd4-1 in regulating IGF-1 dependent signaling 
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(Cao et al., 2008; Monami et al., 2008; Shi et al., 2014), which may account 
for the reduced outgrowth of neurites seen in the Nedd4-1 KO neurons 
(Kawabe et al., 2010). However, the physiological relevance of these findings 
remains unclear and controversial. For instance, Nedd4-1 KO MEFs show a 
downregulation of surface-expressed IGF-1 receptor (IGF-1R) and reduced 
IGF-1 signaling (Cao et al., 2008), whereas RNAi-mediated KD of 
endogenous Nedd4-1 in MEFs leads to increased IGF-1-induced cellular 
responses (Monami et al. 2008). Based on my current finding that Nedd4-1 
expression is positively regulated through mTORC1 and other published 
results, I propose that Nedd4-1 may play a role in regulating IGF-1 signaling. 
In the study by Monami et al (2008), the authors concluded that Nedd4-
1 interacts with growth factor receptor bound protein 10 (Grb10), an adaptor 
protein that binds to IGF-1R, and that the formation of a Nedd4-1/Grb10/IGF-
1R complex facilitates monoubiquitination of surface-expressed IGF-1Rs by 
Nedd4-1, leading to the internalization of IGF-1Rs. This model is consistent 
with the finding that KD of Grb10 causes upregulation of IGF-1 signaling 
(Dufresne and Smith, 2005). However, KD of Grb10 also increases IGF-1R 
surface expression in the absence of Nedd4-1 (Cao et al., 2008), indicating 
that Grb10 can negatively regulate IGF-1 signaling independent of Nedd4-1.  
While in the present study I found that Nedd4-1 mRNA is a target of 
mTORC1-dependent signaling during translation, recently published studies 
revealed that Grb10 is a direct phosphorylation substrate of mTORC1. 
Phosphorylation of Grb10 by mTORC1 increases Grb10 protein stability, 
leading to a Grb10-mediated negative feed-back loop to downregulate IGF-1 
signaling (Hsu et al., 2011; Yu et al., 2011). Of note, the phosphorylation 
sites of Grb10 targeted by mTORC1 (S501 and S503) are located just next to 
the Nedd4-1 binding region (Huang and Szebenyi, 2010). This raises the 
possibilities that phosphorylation of Grb10 by mTORC1 may interfere with its 
binding to Nedd4-1, and that the binding of Grb10 to Nedd4-1 may prevent 
Grb10 from being phosphorylated by mTORC1. In accordance with this 
notion, Grb10 expression is upregulated upon Nedd4-1 downregulation, 
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although Nedd4-1 does not ubiquitinate Grb10 or target it for degradation 
(Cao et al., 2008; Morrione et al., 1999). Taken together, in Nedd4-1 KO cells 
there may be an increased level of phosphorylated and stabilized Grb10, 
leading to downregulation of IGF-1 signaling in a Nedd4-1 independent 
manner, whereas Nedd4-1 could bind to the non-phosphorylated form of 
Grb10 to mediate the monoubiquitination and internalization of IGF-1Rs 
(Figure 4-1). The actual mechanism by which Nedd4-1 levels affect the 
Grb10 phosphorylation by mTORC1, however, remains to be determined.  
Figure 4-1. Model of Regulation of IGF-1 Signaling by Nedd4-1 and 
Grb10 
(A) Nedd4-1 interacts with the adaptor protein Grb10, enabling Nedd4-1 to 
mediate the monoubiquitination and internalization of IGF-1Rs, which further 
leads to decreased IGF-1 signaling. (B) Binding of Nedd4-1 to Grb10 may 
hinder the phosphorylation of Grb10 by mTORC1. Phosphorylation of Grb10, 
on the other hand, may also interfere with Grb10 binding to Nedd4-1. Grb10 
can downregulate IGF-1 signaling independently of Nedd4-1, but may 
cooperate with some yet unknown proteins for this purpose. 
4.3 Opposing Roles of Usp9x and WWP1/WWP2 in the 
Development of Mammalian Neurons 
In the present study, I identified the deubiquitinase Usp9x as a binding 
partner of WWP1/WWP2 (Figures 3-13 and 3-14). Usp9x is highly expressed 
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in the mammalian CNS and has been shown to deubiquitinate several 
molecules involved in neurodevelopmental signaling, such as β-catenin in 
Wnt signaling (Taya et al., 1999) and Smad4 in TGF-β signaling (Xie et al., 
2013). Usp9x also interacts with doublecortin, a microtubule-associated 
protein involved in neuronal migration (Friocourt et al., 2005). These studies 
indicate that Usp9x may have important functions in the regulation of multiple 
stages of mammalian neuronal development. Accordingly, conditional KO of 
Usp9x in mouse neural progenitor cells (Nestin-Cre;Usp9xf/f) causes 
perinatal lethality, disrupted cortical architecture, and impaired axon 
morphogenesis (Homan et al., 2014). 
In addition, it has been reported that the C-terminus of Usp9x interacts 
with the second WW domain of Itch and Smurf1, two other E3 ligases in the 
Nedd4 superfamily (Figure 1-4). Usp9x inhibits the autoubiquitination of Itch 
and Smurf1, leading to increased stability and activity of the ligases. On the 
other hand, Usp9x is not a direct substrate of Itch or Smurf1 (Mouchantaf et 
al., 2006; Xie et al., 2013). Given the structural similarity between the WW 
domains of Itch, Smurf1, WWP1, and WWP2 (Figure 1-4), Usp9x may play a 
similar role in counteracting the activity of WWP1/WWP2 as it does with Itch 
and Smurf1. Of note, Usp9x has been identified as the deubiquitinase for 
Nuak1, an AMP-activated protein kinase (AMPK)-related kinase that acts 
downstream of LKB1 to regulate axonal terminal branching in mouse cortical 
neurons (Courchet et al., 2013). Deubiquitination of Nuak1 by Usp9x inhibits 
LKB1-mediated Nuak1 phosphorylation and activation in non-neuronal cells 
(Al-Hakim et al., 2008). Interestingly, in an in vitro binding assay I found that 
WWP1 and WWP2 also interact with Nuak1 and Nuak2, the closest 
homologue of Nuak1 in mammals (Figure 3-14). These results are 
compatible with the notion that although WWP1/WWP2 do not ubiquitinate 
Usp9x (Mouchantaf et al., 2006; Xie et al., 2013), they may counteract the 
functions of Usp9x by ubiquitinating an effector protein that is also targeted 
by Usp9x, such as Nuak1 and Nuak2. This model (Figure 4-2) also indicates 
that WWP1/WWP2 may play important roles in multiple processes of 
neuronal development. The binding between Usp9x and WWP1/WWP2, in 
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addition, may operate to bring the deubiquitinase and the ligase to the same 
intracellular location in order to efficiently fine-tune a highly dynamic cellular 
process such as axon morphogenesis. 
Figure 4-2. Model of Opposing Roles of Usp9x and WWP1/WWP2 in 
Axon Morphogenesis 
LKB1 mediates the phosphorylation and activation of Nuak1/Nuak2, and this 
regulation is important for axon morphogenesis. Ubiquitination of 
Nuak1/Nuak2 inhibits their phosphorylation and activation mediated by LKB1, 
and Usp9x removes such inhibition by deubiquitinating Nuak1/Nuak2. Usp9x 
is a binding partner of WWP1/WWP2 and may lead to increased stability and 
activity of WWP1/WWP2 by inhibiting the autoubiquitination of the ligases. 
WWP1/WWP2 interact with Nuak1 and Nuak2 and may mediate their 
ubiquitination, counteracting the function of Usp9x in axon morphogenesis. 
4.4 Regulation of Cdk5 by WWP1/WWP2-Mediated 
Ubiquitination 
Cdk5 is a unique member in the Cdk family with important roles in the 
CNS. Misregulation of Cdk5 leads to defects in neuronal development and 
multiple neuronal diseases (reviewed by Dhavan and Tsai, 2001; Su and 
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Tsai, 2011). In keeping with its prominent and diverse functions, Cdk5 is 
tightly regulated at multiple levels, including posttranslational modifications of 
Cdk5. Here, I identified WWP1 and WWP2 as E3 ligases that mediate K63-
linked polyubiquitination of Cdk5 (Figures 3-15, 3-16, and 3-17). This type of 
ubiquitination does not target Cdk5 for proteosomal degradation but is likely 
involved in the regulation of other functional aspects of Cdk5, such as kinase 
activity or intracellular localization of Cdk5.  
Cdk5 is regulated by various posttranslational modifications. 
Phosphorylation of Cdk5 at tyrosine 15 (Y15) by c-Abl increases the kinase 
activity of Cdk5, and this phosphorylation can be facilitated upon binding of 
Cdk5 with Cable, an adaptor protein to c-Abl (Zukerberg et al., 2000). Cdk5 
is also phosphorylated at Y15 by Fyn, a member of the Src family of non-
receptor tyrosine kinases that are associated with neuropilin-1 and 
plexinA1/A2, receptors for Semaphorin-3A (Sema-3A). This pathway, in 
which phosphorylation of Cdk5 at Y15 by Fyn upon Sema-3A stimulation, is 
important for the Sema-3A induced growth cone collapse and the dendrite-
axon orientation of mouse cortical neurons (Sasaki et al., 2002). Moreover, 
one report showed that Cdk5 is S-nitrosylated at Cysteine 83, and such S-
nitrosylation inhibits the Cdk5 kinase activity and the associated neurite 
outgrowth during neuronal development (Zhang et al., 2010). Ubiquitination 
of Cdk5, on the other hand, has only been reported to be mediated by the E3 
ligases cdh1-APC, leading to proteosomal degradation of Cdk5 (Zhang et al., 
2012). In the present study, I found that Cdk5 is polyubiquitinated by 
WWP1/WWP2 via K63-linked chains for purposes independent of 
proteasomal degradation (Figures 3-15 and 3-17). Such ubiquitination of 
Cdk5 may be involved in the regulation of Cdk5 activity, which is similar to 
the phosphorylation or S-nitrosylation of Cdk5. The issue of which lysine 
residue in Cdk5 is ubiquitinated by WWP1/WWP2, however, remains to be 
resolved. 
Activation of Cdk5 is dependent upon binding to its activators p35 and 
p39, which have partially complementary temporal and spatial expression 
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patterns in the CNS (Wu et al., 2000; Zheng et al., 1998). As the main 
activator of Cdk5 in the cerebral cortex and hippocampus, p35 is a short-
lived protein with a half-life of only 20 to 30 minutes. Once p35 binds to Cdk5, 
it is phosphorylated by Cdk5, resulting in rapid ubiquitination and degradation 
of p35 (Patrick et al., 1998). The unstable nature of the p35 protein 
underscores the importance of regulating p35 expression levels. It has been 
reported that application of the extracellular glycoprotein, laminin, to cultured 
neurons or the SH-SY5Y neuroblastoma cell line results in increased p35 
mRNA and protein levels as well as the corresponding Cdk5 activity (Li et al., 
2000; Paglini et al., 1998). In addition, induction of the transcription factor 
early growth response 1 (EGR1) by the extracellular-signal-regulated kinase 
(ERK) cascade also leads to the upregulation of p35 expression. Importantly, 
I found that the Cdk5 ubiquitination mediated by WWP1 in vitro is 
substantially reduced in the presence of high-levels of p25, an N-terminally 
truncated form of p35. This result indicates that binding with p25 blocks the 
ubiquitination of Cdk5 by WWP1, or, on the contrary, that ubiquitination of 
Cdk5 by WWP ligases may interfere with the binding of p25 to Cdk5 and thus 
affect Cdk5 activation (Figure 3-17 C). 
In view of the fact that K63-linked polyubiquitination of proteins may 
lead to changes in protein localization (reviewed by Ikeda and Dikic, 2008), 
the ubiquitination of Cdk5 by WWP1/WWP2 may regulate the cellular 
localization of Cdk5. Of note, in the N-terminus of p35 there is a 
myristoylation signal motif that operates to target the p35/Cdk5 complex to 
the membrane. Accordingly, many of the identified physiological substrates 
of Cdk5 are located at the cell membrane (reviewed by Su and Tsai, 2011). 
The calpain-mediated conversion of p35 to p25, an N-terminally truncated 
form of p35, leads to the cytosolic localization of activated Cdk5 and 
aberrantly increased Cdk5 activity, because of the loss of the myristoylation 
signal motif on p25 and the prolonged half-life of p25 as compared to p35 
(Patrick et al., 1999). In addition, the nuclear localization of Cdk5 appears to 
play important roles for neuronal protection upon stress or insult, since loss 
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of the nuclear Cdk5 has been linked with the cell-cycle re-entry of postmitotic 
neurons, leading to neuronal cell death (Zhang et al., 2008).  
In summary, the localization and activity of Cdk5 are vital for the proper 
functions of various cellular processes in the central nervous system and 
should be tightly regulated. Ubiquitination of Cdk5 by the WWP E3 ligases, 
WWP1 and WWP2, may contribute to the regulation of Cdk5 and thereby 
have important roles in neuronal development. 
4.5 Conclusions and Outlook 
In the classical view of protein ubiquitination, substrate proteins are 
conjugated with K48-linked polyubiquitin chains and targeted for proteosomal 
degradation. Recent progress, however, indicates that target proteins may 
undergo polyubiquitination that is conjugated via the other six lysine residues 
of the ubiquitin moiety. This sophisticated nature of protein ubiquitination 
contributes another layer of complexity and results in obstacles to study its 
physiological roles. Given that the ubiquitin E3 ligases govern the substrate 
specificity, studies focusing on the functions and regulation of a certain E3 
ligase offer an entry point to understand the possible roles of protein 
ubiquitination in defined cellular processes. The present work has focused on 
the characterization of the E3 ligases Nedd4-1, Nedd4-2, WWP1, and WWP2 
in the regulation of neuronal development. These ligases are members of the 
HECT-type Nedd4 superfamily that have been shown to preferentially 
conjugate substrate proteins with monoubiquitin or K63-linked polyubiquitin 
for non-proteolytic purposes (Kamadurai et al., 2013; Kim and Huibregtse, 
2009; Polo et al., 2002). 
In the first part of the study, I investigated the roles of Nedd4-1 and 
Nedd4-2 in axon morphogenesis of mammalian CNS neurons, and I found 
that Nedd4-1/Nedd4-2 promote axon outgrowth in mouse hippocampal and 
cortical neurons (Figures 3-1, 3-3, and 3-4). While xNedd4 was shown to 
promote axon growth in Xenopus laevis retinal ganglion cells by targeting 
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PTEN for proteosomal degradation (Drinjakovic et al., 2010), I found no 
evidence of misregulation of PTEN that could contribute to the axonal growth 
defects observed in Nedd4-1;Nedd4-2 KO neurons. These results argue 
against the belief that PTEN is targeted by Nedd4-1 or Nedd4-2 in general 
cellular processes. In contrast, I found that PTEN negatively regulates 
Nedd4-1 expression at the translational level by antagonizing PI3K-mTORC1 
signaling, and that this regulation is important for neurite outgrowth. Of note, 
these findings are in accordance with the notion that Nedd4-1 mRNAs are 
targeted by the translational machinery in growing neurites and raise the 
possibility that Nedd4-1 expression can be spatially and temporally controlled 
in the cells. Given that accumulating evidence indicates the importance of 
local mRNA translation in neuronal axon guidance and synaptic plasticity, 
additional studies on how Nedd4-1 expression is regulated in response to 
extracellular signals with higher spatiotemporal resolution may give further 
insights into the roles of Nedd4-1 in axonal guidance and synaptic plasticity. 
Moreover, independent regulatory programs driven by either PI3K/PTEN-
mTORC1 or Nedd4-1 may interact and regulate the same cellular process. 
For instance, mTORC1 promotes the translation of Nedd4-1 as well as the 
phosphorylation of Grb10, a Nedd4-1 binding partner that may regulate IGF-
1 signaling in a Nedd4-1-dependent or -independent manner (Figure 4-1). 
Future studies should address if and how Grb10 phosphorylation by 
mTORC1 is affected by Nedd4-1 expression. 
In the second part of the study, I identified Usp9x, Nuak1, and Nuak2 as 
binding partners of WWP1/WWP2, and Cdk5 as a physiological substrate of 
WWP1/WWP2. Based on these results and other published data, 
WWP1/WWP2 may have important roles in axon morphogenesis by 
ubiquitinating Nuak1/Nuak2, counteracting the function of Usp9x. In addition, 
ubiquitination of Cdk5 by WWP1/WWP2 may change Cdk5 activity or 
localization, and thereby affect various cellular processes given the vital roles 
of Cdk5 in neuronal development and functions. Future studies on the 
consequences of WWP1/WWP2 deletion in neurons may shed light on how 
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WWP1/WWP2 regulate Usp9x, Nuak1, Nuak2, and Cdk5 via direct 
interaction or ubiquitination. 
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